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ABSTRACT 
ABSTRACT 
 
BACKGROUND AND OBJECTIVES: 
To develop a Dementia screening instrument for Tamil speaking patients, to 
adapt translate and develop normative value of ACE (Addenbroke’s cognitive 
examination) for Tamil speaking patients. 
METHODS: 
Ethical committee clearance was obtained. Consent was taken from 100 
Patients in the age group of 57-77yrs who were diagnosed not to have dementia by 
the neurologists.  
They were then divided into groups based on age, gender, ACE scoring, 
language, education, orientation, attention, concentration, memory, ante grade 
memory, retrograde memory, verbal fluency, comprehension, repetition, reading 
writing visuo-spatial abilities, recall, recognition and perception abilities.   
These were the variables studied along with their association with dementia. 
The data was analysed with the SPSS version 20.0 
RESULTS: 
 With an increase in age the ACE score and increased 
 Higher the education, higher the ACE score.  
 ACE score significantly differed between different age group of our study. 
 65 patients were diagnosed with Dementia out of the 100 patients examined, 
using the Tamil ACE scale. 
 
CONCLUSION: 
 Tamil version of ACE is compatible with the original ACE as far as 
performance, among the normal elders. 
 ACE-score correlates well with education of nor elders. 
 T-ACE appear to be good tool to diagnose Dementia in Tamil speaking 
patients.   
                                                     
KEY WORDS: T-ACE (Tamil Addenbrookes Cognitive Examination) 
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INTRODUCTION 
 
Definition acquired deterioration in cognitive abilities that impairs the 
successful performance of activities of daily living. Episodic memory, the ability to 
recall events specific time and place, is the cognitive function most commonly lost. 
India, a country which is considered to be one of the countries with the largest 
population of old people, needs to have an organized and efficient way of addressing the 
mental health of aged people.[1] The overall population of elderly in India is expected to 
reach over 150 million in the next few years.[2] Owing to this spike in the population it is 
expected that conditions like dementia would be reported more often than now. There have 
been many studies that emphasizes on the increasing number of cases of dementia.[3] The 
occurrence of dementia in India in the recent years was estimated to be around 1.4% in 
people above the age of 65.[4] In people above the age of 60, it was estimated to be above 
3.5% where they came from a rural background.[5] The rate of affliction for people above 
the age of 65 years from urban settings was estimated to be above 2.44%.[6] The increasing 
rates of dementia reported in India currently indicates 10.6% in people above the age of 65 
in rural areas while it was 7.5% for people in urban areas.[7]  
Dementia is an umbrella term for a group of diseases causing a progressive 
and irreversible cognitive decline in elderly people including Alzheimer’s disease, 
Fronto-temporal dementia and others. The affected person gradually loses the ability to 
manage their own life and experiences difficulties in everyday activities including 
personal care. In 2005 the estimation of people having dementia worldwide was 24.3 
million and an annual increase of 4.6million new cases was anticipated (Hummelová-
Fanfrdlová et al., 2006).As already mentioned, there is an increasing number of older 
patients with suspected dementia. Consequently, there is a high demand for the 
development of a screening method which would be brief, sensitive to early cognitive 
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deficits and also easy to administer (Konstantinopoulou et al., 2011).The most 
commonly used screening method for cognitive impairment detection is certainly the 
Mini Mental State Examination (MMSE). Its great advantage is the brevity, easy 
administration and wide accessibility for clinicians, GPs or care workers since no 
special training is required for its use (Raisová et al., 2011)Even if MMSE is used 
worldwide and accepted as a valid tool for dementia detection, there is still more 
evidence showing that the test has several limitations and insufficiencies (Hoops et al., 
2009).The Montreal Cognitive Assessment (MOCA) is another cognitive screening test 
which might be used in dementia diagnosis. It is a brief 30-point assessment examining 
various cognitive abilities. The task assessing the short-term memory contains learning 
of five words and their delayed recall. Clock drawing task and drawing of 3- 
dimensional cube are used to examine individual’s visuo-spatial abilities. Picture 
naming task, repetition of sentences and verbal fluency task are used to assess the 
language abilities of the individual. Several items are assessing also attention, 
concentration, orientation or working memory (Nasreddine et al., 2005). ACE is a brief 
bedside neuropsychological screening battery that provides a detection of mild 
dementia and is also efficient in differential diagnosis since it is able to distinguish 
between Alzheimer’s disease and Fronto-temporal dementia (Larner, 2007). It 
incorporates all the MMSE which is expanded on the items assessing the cognitive 
domains such as memory, visuo-spatial abilities or language and also includes the 
subtest evaluating the verbal fluency (Yoshida et al., 2009). This dementia screening 
tool has been adopted in many countries and translated into various languages because 
its sensitivity, specificity and accuracy for dementia diagnosis have been confirmed by 
several validation studies (Konstantinopoulou et al., 2011).The ACE-R is, however, a 
relatively new testing method and not as widely studied and used as its original version 
ACE. Even though the countries which currently use their own version of ACE-R 
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report its benefits, there is still need to test this tool across the world and adapt it cross-
culturally (Carvalho et al., 2012). 
It is critical that cognitive impairment and dementia is detected early. 
Managing the condition may require different strategies based on the severity and 
occurrence of the condition.[8] Clinics called as specialized memory clinics help in 
identifying and treating the condition more comprehensively. Assessments could help 
in providing differential diagnoses of subtypes of dementia. Alzheimer’s disease and 
vascular dementia are identified as two of the major kinds of dementia in some 
geographical areas.[9]  
Among developing countries, as elsewhere, Alzheimer’s disease and 
vascular dementia are the two most common types of dementia observed.[9] The 
diagnosis of MCI could be difficult in specific ethnic communities as there would be no 
sufficient normative data in a country as vast as India. There are research communities 
that have carried out assessments like neuropsychological tests irrespective of a cultural 
context. Alzheimer’s has been diagnosed based on this DSM-IV criteria.[10] A lot of 
standard procedures are also available that characterizes Alzheimer’s disease and 
vascular dementia.[11, 12] 
Cognitive impairment could be diagnosed in certain ethnic communities using 
neuropsychological evaluations.[13] This proves to be advantageous for implementing 
the evaluation methods for dementia in countries like India. It also evaluates the 
effectiveness of dementia tests in hospitals for analysing cognitive impairment. The 
prevalence of memory clinics in India is very less. India has a very vast and diverse 
cultural setting and the services provided by the clinics has to accommodate the 
challenges of language and cultural diversity. The current research uses elderly subjects 
for evaluating dementia using normal procedures. The difficulties in analysing 
cognitive disorders have also been studied extensively.  
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AIMS AND OBJECTIVES 
 
1. To adapt translate and develop normative value of ACE (Addenbrook’s 
cognitive examination) for Tamil speaking patients.  
2. To know the prevalence of dementia in patients, coming to Sree Mookambika 
Institute of medical sciences, Kulasekharam 
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REVIEW OF LITERATURE 
 
Definition of Dementia  
Dementia is a clinical syndrome characterized by “a global deterioration of 
mental functioning in its cognitive, emotional and conative aspects” [14]  
Historical background 
 In the 1940s, Mayer-Gross, Guttman[15] and others identified the 
fundamental defects that constitute the syndrome of dementia. Memory impairment 
that is evident in learning, retention and recall of both new information and the 
distant past was considered essential to the diagnosis. However, dementia is more 
than just forgetfulness [16].  
The various neurological features (are often more directly determined by the 
location and severity of the brain damage.[17,18] At least one of the following 
symptoms primary symptoms or the primary symptoms is usually required as well:  
• Impairment of thinking,  
• Reasoning,  
• Communication,  
• Orientation,  
• Practical abilities, ie,  
o  Greater difficulty maintaining learned skills or  
o  Managing everyday activities, and 
o Personality changes resulting in  
 Lack of insight and judgment,  
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 Disinhibition,  
 Aggressiveness,  
 Emotional bluntness and  
o Lack of empathy [14,19].  
Other psychiatric features referred to as the secondary or accessory 
symptoms such as  
 Anxiety,  
 Depression,  
 Suspiciousness,  
 Delusions,  
 Obstinacy and  
 Anancastic-like behavior, seem to be more related to the patient’s 
awareness of, and reactions and responses to, cerebral dysfunction and its 
consequences.  
These secondary or accessory symptoms are also influenced by the patient’s 
premorbid personality and previous experience, as well as related to better preserved 
brain functions.[20]  
Recently introduced terms such as treatable dementia.[21,22] reversible 
dementia [21-23] and mild cognitive impairment (MCI)[25,26] highlight the clinical and 
etiological variability of such conditions. 
Pseudodementia coined by Carl Wernicke earlier termed as demence 
melancholique refers to a dementia-like clinical state in where symptoms of 
cognitive, emotional and cognitive dysfunction were regarded as secondary to a non-
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organic mental disorder. Pseudodementia means a chronic hysterical states, 
mimicking mental weakness.27 
The primary criterion for diagnosis of dementia is evidence of a decline in 
both memory and thinking, leading to significant impairment of functioning 
compared with previous levels.28 
Dementia is a clinical syndrome caused by neurodegeneration (Alzheimer’s 
disease, vascular dementia, Lewy body, and frontotemporal dementia being the most 
common underlying pathologies) and characterized by inexorably progressive 
deterioration in cognitive ability and capacity for independent living. 
Types of Dementia 
“Benign senescent forgetfulness”[29,30], “age associated mental impairment” 
(AAMI) [31-33] and “mild cognitive impairment” (MCI) have been adopted to 
indicate alternative interpretations of cognitive decline with increasing age. 
“Ischemic Vascular Dementia” (IVD) in 1992, describing probable, possible, 
and definite IVD, as well as “mixed dementia” [34]. VaD was also defined in terms of 
brain imaging, thereby extending the concept to include MID, “single stroke 
dementia” and Binswanger’s disease.  
A third major category, sometimes called “other secondary dementias”. This 
category contains miscellaneous types of dementia, including the majority of 
presently treatable conditions, such as those caused by hydrocephalus [35-37], 
endocrine, metabolic and nutritional disorders[38,39] infections and exposure to toxic 
factors. There are substantial geographic, ethnic and socioeconomic variations with 
regard to the presence of some of these etiological variables. The further 
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development of neuroimaging, biochemical markers, genetic markers and treatment 
strategies will gradually add to our knowledge in this field. Neuropathology remains 
the gold standard for definitive diagnosis of dementia. A decline in post mortem 
examinations will severely limit our knowledge of normal aging and the true 
prevalence of different types of dementia. 
Alzheimer’s disease: During the course of Alzheimer’s disease, excessive and 
abnormally folded proteins accumulating in the brain result in the formation of 
protein ‘plaques’ around neurones and ‘tangles’ inside neurones, leading to the death 
of these brain cells, particularly in the region responsible for memory. The levels of 
neurotransmitters (chemical ‘messengers’) are also affected, disrupting 
communication within the brain. A combination of factors including age, genetic 
inheritance, environmental factors, diet and overall general health contribute to the 
onset and progression of the disease. Vascular dementia stroke or a series of small 
strokes may cause damage to the network of blood vessels (the vascular system) that 
transport blood within the brain. The resulting disruptions in the supply of oxygen 
(which is transported in the blood) can lead to the death of brain cells, resulting in 
the symptoms of this type of dementia. Risk factors for vascular dementia include 
high blood pressure, heart problems, high cholesterol and diabetes. The type of 
permanent brain damage caused by the interruption in the supply of blood to the 
brain during a stroke depends on which area of the brain has been damaged. ‘Single-
infarct’ vascular dementia is caused by a single stroke that results in death of the 
brain cells in one, relatively large, area. ‘Multi-infarct’ vascular dementia is caused 
by a series of small strokes over time which cause death to brain cells in many 
relatively small areas, but which may not necessarily be noticed at the time by the 
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individual experiencing them. Vascular dementia may also be a result of ‘small 
vessel disease’ (also known as ‘sub-cortical vascular dementia’, or Binswanger’s 
disease), in which blood vessels lying deep in the brain become damaged.  
Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) 
Lewy bodies are spherical protein deposits that build up in brain cells, interfere with 
the chemical ‘messengers’ in the brain, and disrupt the brain’s normal functioning. 
The precise mechanisms by which the Lewy bodies cause damage in the brain are 
not yet well understood. Lewy bodies are also found in the brains of people with 
Parkinson’s disease, and a significant number of people with Parkinson’s disease 
will also go on to develop dementia.16 The relationship between DLB and PDD is 
complex: it is thought that while the two conditions are part of the same continuum, 
they produce different signs and symptoms as a result of the different distribution of 
Lewy bodies in the brain [45]. 
ETIOLOGY  
Age 
Although young-onset cases are increasingly recognized, dementia is 
typically a condition that affects older people (44) Dementia incidence increases 
exponentially with age between the ages of 65 and 90 years and doubles 
approximately every 5 years. (32) 
Approximately 5 to 8 %  have dementia at age 65 to 70 years ,15 to 20 % 
have dementia at age 75 to 80 years, up to 40 to 50 % have dementia over age 85 
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Type of dementia  
Alzheimer's disease is most common dementia accounts for 50-75%, 
Dementia with Lewy bodies accounts for 15 to 35 %, Vascular dementia accounts 
for 5 – 20 % 
Gender 
There is a lower risk of dementia among women with higher levels of 
education, but not among men. A meta-analysis of European studies found a similar 
result in participants younger than 90 years.[41,42] 
PATHOLOGY 
The prevalence of dementia is expected to increase three fold in the next 40 
years13. Dementia can be caused by a wide range of pathological entities. Every 
dementia subtype has a specific pathogenesis and risk factors that must be 
understood in order to develop prevention and treatment strategies 
Based on the etiology  
 Neurodegenerative Alzheimer's Ds; Dementia with Lewy Bodies; 
Frontotemporal Dementia; Parkinson’s Ds  
 Vascular Infarction; Hemodynamic Insufficiency  
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Table 1: Causes of Dementia[30] 
A.MULTIFOCAL/DIFFUSE DISEASE: 
1. Large vessel dementia (LVD): 
Multiple infarct dementia (MID): multiple large artery /borderline infarcts ,cortical & 
subcortical, with perifocal lesions in gray & white matter 
2. Small vessel dementia(SVD): 
 Subcortical infarct dementia: 
 Multiple small lacunar infarct with perifocal lesions in white  matter. 
 “ Granular atrophy “ of cortex ( multifocal cortical micro infarct) 
 Lacunes & multilacunar state 
 Binswanger subcortical (leuco)encephalopathy 
 Hereditary angiopathies- CADASIL( Cerebral Autosomal  
 Dominant Arteriopathy with Subcortical  Infarcts & Leucoencephalopathy ) & 
others. 
 Cortical plus subcortical dementia: 
 Multiple, restricted small infarcts due to:  
 Hypertensive  arteriolo sclerotic angiopathy 
 Cerebral amyloid angiopathy, with or without hemorrhages 
 Collagen or inflammatory vascular disease(angitis, PCNSA, FMD) 
 Hereditary forms of CAA 
3. Hypoperfusive ,hypoxic-ischemic dementia(HHD): 
 Incomplete white matter infarcts 
 Anti-PL related ischemia 
 Diffuse ischemic hypoxic ischemic encephalopathy( cortical lacunar necrosis, 
post cardiac arrest , hypotension) 
4.Venous infarct dementia: 
 Large hemorrhagic, congestive symmetric infarcts due to thrombosis of  the 
sagittal sinus or great vein of galen. 
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5.Hemorrhagic dementia: 
 Subdural haemorrhage  
 Subarachnoid haemorrhage  
 Intracerebral hemorrhage   
 Multiple microbleeds , particularly subcortical. 
B.FOCAL DISEASE/STRATEGIC INFARCT DEMENTIA(SID): 
 Small infarcts restricted to functional important region 
 Mesial temporal (including hippocampal) infarcts/ ischemia/sclerosis 
 Caudate & thalamic infarcts(especially DM nucleus, bilateral lesions) 
 Fronto-cingulate infarcts (basal forebrain,ACA). 
 Angular gyrus infarct (dominant cerebral hemisphere- ACA and MCA  
territories) 
 White matter key areas 
 Anti-PL, anti-phospholipid; PCNSA, primary angitis/arteritis of the central 
nervous system; FMD,fibromuscular dysplasia; ACA,anterior cerebral artery ; 
DM,dorsomedial;CAA,cerebral amyloid angiopathy.  
 
o Neurological Multiple Sclerosis; Normal Pressure Hydrocephalus  
o Endocrine Hypothyroidism  
o Nutritional Def. Of Vit. B12, Thiamine, Niacin  
o Infectious Hiv; Prion Ds; Neurosyphilis; Cryptococcus  
o Metabolic Hepatic/ Renal Insufficiency; Wilson’s Ds  
o Traumatic Subdural Haematoma; Dementia Pugilistica  
o Toxic Agents Alcohol; Heavy Metals; Anticholinergic Med; Co 
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Based on the reversibility  
 Reversible Dementia [43] 
 Delirium 
 Emotions (depression)& Endocrine Disease 
 Metabolic Disturbances 
 Eye & Ear Impairments 
 Nutritional Disorders 
 Tumors, Toxicity, Trauma to Head 
 Infectious Disorders 
 Alcohol, Arteriosclerosis 
 Ireversible Dementia[45] 
 Alzheimer’s  Lewy Body Dementia 
  Pick’s Disease (Frontotemperal Dementia) 
  Parkinson’s 
  Vascular 
 Huntington’s Disease 
 Jacob-Cruzefeldt Disease 
Based on the location  
1. Cortical Dementia 
2. Subcortical Dementia 
3. Mixed 
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SIGNS AND SYMPTOMS 
Depending on the stage at which it is diagnosed, the indications of dementia 
may be distinct to a large extent [37]. The commonly afflicted areas are the cognitive 
and visual special capabilities. The progression of the disease is slow and continuous.  
The different symptoms progress with time, but at a variable rate, and 
according to the regions of the brain affected by the underlying disease. Other forms 
of dementia tend not to be characterised into formalised ‘stages’ in quite the same 
way. A very low percentage (upto 10 percent) of the patients afflicted with dementia 
have a condition termed as mixed dementia. The condition is associated with 
Alzheimer’s disease and the frontotemporal or vascular dementia. The symptoms 
could be evident as: [40] 
 Tremor and loss of balance. 
 Difficulties in speech 
 Issues in swallowing  
 Distorted memory 
 Meandering behaviour 
 Issues in vision [41] 
In addition to these symptoms certain other behavioral issues accompany 
dementia which may be shown as [42][43] 
 Agitation 
 Depression 
 Tension and restlessness 
 Uncontrolled motor behaviour 
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 Elation 
 Irritation 
 Uncaring attitude 
 Impulsiveness 
 Unreasonable thoughts bordering delusions 
 Altered sleep and appetite patterns 
It has often been noticed that when the patients face situations that they are not 
able to manage, they may have an immediate reaction of despair or displeasure.  Previous 
analysis also mentions that dementia is often accompanied psychosis and animosity.[46] 
Cognitive testing 
The normal testing procedures for dementia are short and brief that may 
range between 5 and 15 minutes 
 MMSE 
 3MS  
 AMTS  
 abbreviated mental test score (AMTS),  
 the, Modified Mini-Mental State Examination (3MS 
 the Cognitive Abilities Screening Instrument (CASI 
 Trail-making test,[61] and the clock drawing test 
 The MOCA (Montreal Cognitive Assessment) is a very reliable 
screening test and is available online for free in 35 different languages. 
The MOCA has also been shown somewhat better at detecting mild 
cognitive impairment than the MMSE. 
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 Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) 
 General Practitioner Assessment Of Cognition [47] 
Table 2 Classification of Dementia48 
 AD VaD LBD FBD 
History 
Gradual onset and 
progression 
Abrupt or gradual 
onset. 
Step wise or 
gradual 
progression. 
Insidious onset. 
Progression 
with 
fluctuations. 
 
Early 
onset,insidious 
onset. 
Rapid progression 
Physical 
signs and 
symptoms 
Normal gait, 
normal 
neurological exam 
in the early to mid 
stages. 
Gait 
abnormalities, 
signs of vascular 
disease and focal 
neurological 
signs. 
Shuffled gait, 
increased tone, 
tremors, slow 
moving. 
At the Late 
stage,patients 
develop gait 
abnormalities 
along with 
primitive reflexes. 
Other signs 
and 
symptoms 
Memory loss, 
language deficits, 
mood swings and 
personality 
changes 
Memory loss, 
language deficit, 
dysarthria, 
emotional 
liability, 
decreased 
concentration. 
Depression, 
hallucinations,v
ariable in terms 
of day to day 
symptoms. 
Poor judgement, 
social withdrawal 
and socially 
inappropriate 
behaviour. 
Imaging 
Generalized 
atrophy with noted 
medial Temporal 
lobe atrophy. 
Strokes, lacunar 
infarcts, white 
matter lesion are 
noted 
Generalized 
atrophy 
throughout 
Frontal and 
temporal lobes are 
atrophied 
Pathology 
Beta amyloid 
plates and neuro-
fibrillary tangles. 
Cerebro vascular 
disease due to 
common cerebro- 
vascular risk 
factors. 
Lewy bodies 
are present in 
both the cortex 
and the mid 
brain areas. 
Absence of 
plaques and 
tangles. Pick cells 
and bodies are 
present in the 
cortex 
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Figure 1. Etiology of Dementia49 
 
INVESTIGATIONS ASSESSMENTS  
Complete blood count, serum electrolytes, renal and hepatic function, 
glucose, albumin and protein, vitamin B12 and folate, rapid plasma reagin (syphilis), 
thyroid- stimulating hormone, urinalysis Rule out correctable or contributory causes 
of dementia  
Imaging: Computed tomography without contrast or magnetic resonance 
imaging Rule out infarcts, mass lesions, tumors, and hydrocephalus  
Neurological examination Correlate imaging findings with clinical 
examination Neuropsychological testing Mini-Mental State Examination: Screening 
test of cognitive function[50] 
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DIFFERENTIAL DIAGNOSIS   
 Delirium   
 Mild Cognitive Impairment  
 Age-Related Cognitive Decline   
 Mental Retardation   
 Schizophrenia  Depression 
 Factitious D/O 
 Alcohol Abuse 
DEMENTIA INCIDENCE 
Particularly rapid increases in the numbers and proportion of older people 
are forecast for China, India, and Latin America. 
By 2050, the number of people aged ≥60 years will have increased by 1.25 
billion, accounting for 22% of the world’s population, with 79% living in the world's 
less developed regions. [52] 
TRENDS IN PREVALENCE OVER TIME 
The Impact of Dementia  
One of the major reasons for impairment in elderly people across the world 
is dementia. Even though an elderly patient is subjected to physical disability, they 
can adjust to the limitations fairly well. But this is in stark contradiction to the 
impairment that happens to the cognitive senses. Dementia can make an individual 
seriously impaired, unable to handle their basic tasks (5).  The condition is 
associated with the need to have a caregiver for helping the patient get through their 
daily routines. The caregiver provides their services from the onset of the disease till 
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their death. The care provided by friends, family, and the community is the most 
ideal support system that a patient could get.  
In all world regions, informal care provided by family, friends and the 
community is the cornerstone of the care system.  
LITERATURE 
Mattis S et al54 (1988) The ACE requires more time than the MMSE to 
complete but rarely takes in excess of 15 to 20 minutes, except in very demented 
subjects. It is most useful, however, in patients with early and mild dementia. The 
loss in brevity is offset by a gain in the sensitivity for early dementia and being able 
to predict the type of dementia. Although the ACE is superior to the MMSE, a 
comparison with independent batteries such as the AD Assessment Scale–Cog and 
the Dementia Rating Scale will be valuable. This results apply to a clinic-based 
patient population, age 44 to 88 years, with predominantly degenerative dementia. 
The applicability of the ACE in the community requires investigation. The inter-
rater and intra rater reliability of the ACE could not be evaluated in this 
retrospective analysis, but as the ACE assesses cognitive functions in an objective 
manner the rater related bias is likely to be low. [ 
Lobo et al55 (2000) A total of 2346 cases of mild to severe dementia were 
identified in the 11 studies. Overall, AD was diagnosed in 53.7% of all dementia 
cases, with a range across studies of 38.5% to 78%. The lower prevalence of AD in 
the Italian Longitudinal Study on Aging reflected the high proportion of cases in 
which a subtype of dementia could not be diagnosed. VaD accounted for 15.8% of 
all dementia cases. There was no clear study-specific variation of subtype with age. 
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Fratiglioni L et al56 (2000) the authors examined the association of incident 
dementia and subtypes with age, sex, and geographic area in Europe. Incidence data 
from eight population-based studies carried out in seven European countries were 
compared and pooled. The pooled data included 835 mild to severe dementia cases 
and 42,996 person-years of follow-up. In all studies a higher proportion of cases 
were diagnosed with AD (60 to 70% of all demented cases) than vascular dementia 
(VaD). The incidence of dementia and AD continued to increase with age up to age 
85 years, after which rates increased in women but not men. There was a large 
variation in VaD incidence across studies. In the pooled analysis, the incidence rates 
increased with age without any substantial difference between men and women. 
Surprisingly, higher incidence rates of dementia and AD were found in the very old 
in northwest countries than in southern countries. This study confirms that AD is the 
most frequent dementing disorder in all ages, and that there is a higher incidence of 
dementia, specifically AD, in women than men among the very old. Finally, there 
may be regional differences in dementia incidence.  
Barbeau E et al57 (2004) The results do suggest its potential relevance while 
screening an elderly community for MCI. Cumulative learning trials may prove to 
be a reliable index for initial diagnosis of MCI, but inclusion of additional variables 
from standardized tests should improve the overall accuracy and may represent the 
ideal strategy to identify subjects who need to be closely followed up for 
progression to AD.  
Malaz Boustani et al58 (2005) Dementia is common and undiagnosed in 
primary care. Screening instruments alone have insufficient specificity to establish a 
valid diagnosis of dementia when used in a comprehensive screening program; these 
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results may not be generalized to older adults presenting with cognitive complaints. 
Multiple health system and patient-level factors present barriers to this formal 
assessment and thus render the current standard of care for dementia diagnosis 
impractical in primary care settings.  
Chapman DP et al59 (2006) Dementia represents a diverse category of 
syndromes characterized by deficits in memory, cognitive function, and behavior. 
Symptoms associated with dementia appear to be distributed along a continuum, 
with even subsyndromal presentations affecting the health of older adults and 
meriting intervention. To promote cognitive functioning and independence among 
older adults, public health interventions need to facilitate both early detection and 
treatment of dementia. The availability of adult day care and respite services is 
important in maintaining the health and quality of life of individuals caring for older 
adults with dementia. Recent advances in the treatment of dementia may slow the 
course of cognitive decline, thereby enhancing the quality of life of older individuals 
as well as decreasing costs associated with institutional care. [19] 
Mathurnath et al60 (2010) Prevalence of dementia and AD is higher than any 
reported from the subcontinent suggesting that dementia in Kerala, South India is 
not uncommon. Increasing age increased dementia and AD. Low-education is 
associated with dementia and female-gender with AD. Five-year follow-up of a 
community-based, 77+ old cohort including incident dementia cases was used to 
evaluate the impact of dementia on the risk of death, taking into account other 
chronic conditions potentially related to death, and contrasting Alzheimer's disease 
(AD), and vascular dementia (VaD). In this population, 70% of the dementia cases 
died during the five years after diagnosis, with a mortality rate specific for dementia 
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of 2.4 per 100 person-years. After controlling for socio demographic variables and 
comorbidity, 14% of all deaths could be attributed to dementia with a risk of death 
among demented subjects twice as high as that for non-demented people. Mortality 
risk ratios were 2.0 (95% confidence interval 1.5–2.7) for AD and 3.3 (95% 
confidence interval 2.0–5.3) for VaD. This study confirms that dementing disorders 
are a major risk factor for death. Even in the oldest old (85+), dementia shortens life, 
especially among women. [20] 
Kochan et al61 (2010) Prevalence of MCI ranged from 4 to 70% depending on 
the impairment criteria used. Agreement between different criteria was poor to 
moderate. This lack of consistency had greatest impact on MCI subtype classifications 
with many being reclassified as “normal” or into a different subtype when stringency of 
the criteria was increased or decreased. Higher rates of impairment were found in 
persons of NESB across all cognitive domains.  
Werner et al62, (1999) Literal translation of the phrase ‘no ifs, ands, or 
buts’, is meaningless and has poor sensitivity, specificity and positive predictive 
value. 
P. S. Mathuranath et al63., (2004) over the past three years, experience in an 
Indian population from varying socio economic and educational strata showed that 
simple and literal translation of many items in the ACE provide good 
comprehensibility. In the India less than 8 group, low-level scores were seen for 
22% on visuospatial, and between 4% and 10% on recall, remote memory and 
attention. visuospatial also showed a low mean score of 0.8. As expected, the 
absolute mean scores and the proportion at ceiling on all components were higher in 
India 9 than in the India less than or equal to 8 group. The absolute mean scores 
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were higher for the UK than for the India more than or equal to 9 on all except 
remote memory. For both the groups, however, the proportion at ceiling was more 
than 80% on orientation, attention, language and naming and was less than 25% on 
recall and verbal fluency, thereby suggesting that on these components the 
proportion obtaining the perfect score were relatively comparable between the two 
groups. 
Ganguli et al 64., (1995) developed a Hindi MMSE for a largely illiterate 
(74%) rural population in Ballabgarh in North India. The Hindi translation of the 
selected and modified tests was prepared by a group in New Delhi. A Hindi 
speaking group in Pittsburg then back translated the hindi version into English 
allowing clarification of remaining ambiguities.  
de Silva HA et al. 65, (2002) Due to the high literacy rate in the country, the 
MMSE was translated and modified slightly without having to make major changes 
to the original version. 380 randomly selected subjects over 65 years in a semi-urban 
area were screened with the translated version of the MMSE. The cut-off score for 
cognitive impairment was taken as 17. Of the 380 subjects screened, 33 scored < or 
= 17, and were thus considered cases of suspected dementia. 
Tiwari SC et al.66, (2009) A study conducted among 40 subjects(20 illiterate 
and 20 literate) aged 60 years and above drawn from the urban community. A 
systematically translated Hindi version of MMSE(HVMMSE) was administered. 
After one month, the Hindi Mental State Examination(HMSE) was administrated. 
The two instruments are not in agreement with regard to classifying elderly people 
as having possible cognitive impairment or not. 
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Jones RN et al.67, (2009) Several studies have described comparisons among 
heterogeneous populations on MMSE scores, and emphasized the need to review 
specific differences. Some differences in sub items analysis are due to language 
group differences, such as those described in a report comparing English and 
Spanish-speaking subjects, in which discrepant items were orientation to season, 
state, repeat phrase, and follow command.  
Mathuranath et al.68 (2000): It aimed to validate the ACE as a screening tool 
to detect mild dementia and differentiate between Alzheimer's disease(AD) and 
Fronto-temporal dementia (FTD). Mathuranath et al. (2000) investigated the internal 
consistency, criterion validity and construct validity of the ACE. It was concluded 
that the ACE maintained good sensitivity across different subtypes and severity of 
dementia as defined by Clinical Dementia Ratings (CDR). The CDR provides an 
indicator of an individual’s stage in the disease process. 
Stephanie Crawford,69 in 2010 conducted a study on the diagnostic accuracy 
and clinical utility of the Addenbrooke's Cognitive Examination (ACE) and its 
updated version, the Addenbrooke's Cognitive Examination – Revised (ACE-R), in 
relation to the diagnosis of dementia. A systematic search of relevant databases was 
conducted covering the period 2000 to April 2010 and specific journals and 
reference lists were hand searched. Identified studies that fulfilled the inclusion 
criteria were reviewed using a tailored, methodological quality rating checklist. The 
systematic search process identified 9 studies for review (7 relating to the ACE, 2 on 
the ACE-R). Each study is described individually before strengths and weaknesses 
across studies were considered. Diagnostic accuracy measures were presented for 6 
out of the 9 studies. The studies included in that review convey the ACE and ACE-R 
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as tools capable of providing information on a range of cognitive domains and 
differentiating well between those with and those without cognitive impairment.  
Alexopoulos, A. Ebert, et al70, conducted a study on The diagnostic accuracy 
of the German version of the revised Addenbrooke’s Cognitive Examination (ACE-
R) in identifying mild cognitive impairment (MCI), mild dementia in Alzheimer’s 
disease (AD) and mild dementia in frontotemporal lobar degeneration (FTLD) in 
comparison with the conventional Mini Mental State Examination (MMSE) was 
assessed. The study encompassed 76 cognitively healthy elderly individuals, 75 
patients with MCI, 56 with AD and 22 with FTLD. ACE-R and MMSE were 
validated against an expert diagnosis based on a comprehensive diagnostic 
procedure. Statistical analysis was performed using the receiver operating 
characteristic method and regression analyses. The optimal cut-off score for the 
ACE-R for detecting MCI, AD, and FTLD was 86/87, 82/83 and 83/84, 
respectively. ACE-R was superior to MMSE only in the detection of patients with 
FTLD [area under the curve (AUC): 0.97 vs. 0.92], whilst the accuracy of the two 
instruments did not differ in identifying MCI and AD. The ratio of the scores of the 
memory ACE-R subtest to verbal fluency subtest contributed significantly to the 
discrimination between AD and FTLD (optimal cut-off score: 2.30/2.31, AUC: 
0.77), whereas the MMSE and ACE-R total scores did not. The German ACE-R was 
superior to the most commonly employed MMSE in detecting mild dementia in 
FTLD and in the differential diagnosis between AD and FTLD. Thus it might serve 
as a valuable instrument as part of a comprehensive diagnostic workup in specialist 
centreS/clinics contributing to the diagnosis and differential diagnosis of the cause 
of dementia. 
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Henry Brodaty and Cressida M. Moore71, in 1997 conducted a study to 
examine the reliability and validity of the Clock Drawing Test when used as a 
cognitive screening instrument for mild to moderate dementia, and to compare 
different scoring mechanisms. Retrospective analysis of clock drawing performance 
using three published scoring methods (Shulman, Sunderland and Wolf-Klein) was 
used. A sample of 28 consecutive patients attending the memory clinic for assessment 
who were given a diagnosis of Alzheimer's disease (mild or moderate) and 28 age- 
and sex-matched control subjects comprising 17 memory clinic attenders found to be 
normal and 11 community volunteers were analysed. Sensitivity and specificity of the 
three clock rating scales against memory clinic diagnoses of dementia using DSM-III-
R; their respective interrater reliabilities; and comparisons of each with measures of 
cognitive impairment, daily performance of basic and instrumental activities and 
depression were performed. All methods of scoring the Clock Drawing Test correlated 
well with measures of cognitive impairment (r . 0:57±0:73) and daily performance (r . 
0:38±0:48), were independent of mild depression and demonstrated high sensitivity, 
specificity and interrater reliability. While all clock scales identified mild to moderate 
dementia reasonably well, the Shulman method performed best. In screening for 
dementia, clock drawing proved superior to the MMSE: 24/28 vs 20/28 cases 
identified. When compared with the MMSE, clock drawing provided additional 
diagnostic discrimination, identifying 7/8 AD patients with MMSE scores 524. In a 
clinic population, clock drawing, especially if scored according to the Shulman scale 
and combined with the MMSE, is an extremely efficient test screening measure for 
mild to moderate dementia of the Alzheimer's type with low false negative and false 
positive rates. This may have implications for screening elderly populations. 
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Dagmar Fiedorova1, Petra Krulova, et al72, in 2018, conducted a study on the 
use of Addenbrooke’s Cognitive Examination to compare cognitive function in 
nondemented and nondepressed stroke patients, 3 months after the stroke, with sex- 
and age-matched controls. A total of 156 participants were included (72 controls: 19 
men, mean age 64.5 ± 12.4 years; 84 patients after stroke: 54 men, mean age 62.2 ± 
9.0 years). Statistically significant differences were identified between controls and 
stroke patients in total Addenbrooke’s score (stroke patients, 86.2 points vs controls, 
91.2 points; p<0.01), Verbal Production domain (stroke patients, 9.8 points vs 
controls, 11.5 points; p<0.01), and Memory domain (stroke patients, 19.5 points vs 
controls, 21.7 points; p<0.01). The difference was also statistically significant 
between subgroups of stroke patients and controls: patients with a right-sided brain 
lesion differed from controls in total scores (88.3 vs 91.3 points, respectively; 
p<0.05) and Verbal Production domain scores (9.9 vs 11.5 points, p<0.01), as did 
patients with left-sided brain lesions in total score (83.9 vs 91.3 points; p<0.01) and 
Memory (18.6 vs 21.7 points; p<0.01) and Verbal Production (9.6 vs 11.5 points; 
p<0.01) domains.The study showed  the usability of Addenbrooke’s Cognitive 
Examination 3 months after a stroke to detect mild cognitive decline, providing a 
basis for initiating cognitive rehabilitation as soon as possible.  
Hidenori Yoshida, Seishi Terada, et al.73, in 2009, conducted a study on the 
diagnostic accuracy of the Japanese version of Addenbrooke's Cognitive 
Examination (ACE) in identifying early dementia in comparison with the 
conventional Mini-Mental State Examination (MMSE). Standard tests for evaluating 
dementia screening tests were applied. A total of 201 subjects (65 Alzheimer's 
disease,24 frontotemporal dementia, 26 vascular dementia, 11 dementia with Lewy 
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bodies, 13 mild cognitive impairment , and 62controls) participated in the study. The 
reliability of the ACE was very good (alpha coefficient=0.82). In the patient series, 
the sensitivity for diagnosing dementia with an ACE score of ≤74 was 0.889 with a 
specificity of 0.987, and the sensitivity of an ACE score of ≤80 was 0.984 with a 
specificity of 0.867. The study found out that the Japanese version of the ACE is a 
very accurate instrument for the detection of early dementia, and should be widely 
used in clinical practice.  
Greim, K. Nadler, et al.74, in 2006, conducted a study on the diagnostic 
accuracy of the German version of the Addenbrooke’s Cognitive Examination 
(ACE) in identifying early Alzheimer’s disease (AD) and mild vascular dementia 
(VaD) in comparison with the conventional Mini Mental State Examination 
(MMSE). The study involved 50 patients with mild dementia of AD, 26 patients 
with mild dementia of vascular etiology and 54 cognitively normal subjects. The 
ACE and MMSE were validated against an expert diagnosis based on a 
comprehensive diagnostic workup. Statistical analysis was performed using the 
receiver operator characteristics method. The optimal cut-off score for the ACE for 
detecting dementia in patients with early AD was 85/86, which had a sensitivity of 
93% and a specificity of 86%. The optimal cut-off for the ACE for the identification 
of dementia in patients with mild VaD was also 85/86 and it had a sensitivity of 93% 
and a specificity of 100%. The values imply a substantial agreement between the 
diagnoses made by the ACE and the MMSE. The German version of the ACE is a 
short and practical but accurate test battery for the identification of AD and VaD, 
assessing a broad range of cognitive functions and providing a wide profile of 
cognitive functions/dysfunctions.  
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Davies et al.75 made a study aimed to assess the ACE's ability to differentiate 
between Alzheimer's disease (AD) and Semantic dementia (SD, a subtype of Fronto-
temporal dementia). ACE items were grouped into 12 sub scores and performances 
on these sub scores were compared between the SD and AD groups. SD participants 
performed significantly poorer on naming and reading items, whereas AD 
participants were significantly poorer on orientation items. 
Galton et al. (2005)76:  The aim of this study was to address the relative value 
of the ACE in comparison with more detailed, neuropsychological tests and 
evaluation of the medial temporal lobe (via magnetic resonance imaging, MRI) in 
predicting participant conversion from questionable dementia (QD, a concept similar 
to MCI) to Alzheimer's disease (AD). The ACE had the best combination of Positive 
Predictive Value (PPV) and sensitivity compared to other neuropsychological tests, 
for predicting participant conversion from QD to AD. An ACE cut off of 80 
provided best separation between converters and non converters and was the single 
best predictor of progression to AD  
Reyes et al. (2009)77 This study investigated the validity of the ACE as a 
means of assessing cognitive function in patients with Parkinson's disease (PD). 
Participants from a PD outpatient clinic were recruited (n=44). The Mattis Dementia 
Rating Scale (MDRS) was used as the gold standard reference method. The study 
used a variety of tools to measure the disease progression and the symptoms of 
Parkinson's. The ACE and the MDRS were found to correlate well (r = 0.91, 
p<0.0001), thus it was concluded that the ACE was a valid tool for dementia 
evaluation in PD.  
Review of Literature 
 Page 30 
 
Larner's (2007a)78 study reports ACE data from 285 participants and  
received a full assessment (including 1 year follow-up) and were subsequently 
classified, independently of their ACE performance, as individuals with either 
dementia or non-dementia. The 88 and 83 cut offs reportedly had good sensitivity 
but poorer specificity; an alternative cut off of 75 improved specificity. 
Bak et al.79 (2005): The aim of this study was to examine the cognitive 
profile of three subcortical dementia disorders associated with parkinsonism 
(Progressive supranuclear palsy (PSP), Corticobasal degeneration (CBD) and 
Multiple systems atrophy (MSA) compared with a group of participants with AD 
and a group of healthy controls. The ACE and the Dementia Rating Scale (DRS) 
were used to compare the different participant groups. Two of the subcortical 
dementia groups (PSP and CBD) along with the AD group were significantly 
impaired on the ACE total score, compared to controls; however, the ACE did not 
detect cognitive impairment in the other subcortical group (MSA). 
Mioshi et al.80, 2007 This article introduced the ACE-R and aimed to 
validate the clinical utility of their versions of the ACE. Three groups of participants 
were included in the study: dementia (AD, FTD, LB), healthy controls and MCI. 
Participants were excluded if they had a psychiatric disorder, mixed dementia or 
cognitive impairment caused by something other than a neurodegenerative disease. 
Two cut off scores were defined (88 and 82) based on sensitivity, specificity and 
positive predictive value calculations at different prevalence rates. Participant 
performance on the ACE compared to the ACE-R was investigated; however, it is 
unclear when the ACE and ACE-R were undertaken in relation to each other. A 
subgroup of age and education matched participants was elicited from control, AD, 
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and MCI groups; from these subgroups the MCI group performance was found to be 
between the AD and control groups. MCI patients to be impaired in areas other than 
memory (orientation/attention, verbal fluency, language and visuospatial).The ACE-
R accomplishes standards of a valid dementia scaling test sensitive to early cognitive 
dysfunction. 
Dhara Abhinav Sharma81 et al. (2016) This methodological study was done 
in Ahmedabad institute of medical sciences, Gujarat, India from November 2016 to 
May 2017.In this correlational study, ACE III was translated to Gujarat people by 
using forward-backward-forward method. The results showed that there is strong 
positive correlation between original English version and Gujarati version of ACE 
III with Pearsons correlation coefficient r =0.87 and p = 0.01 The Gujarati version 
correlated with education level of Spearmans correlation coefficient r = 0.75, p = 
0.05 and the original English version of ACE III also correlated with education level 
of older adult with Spearmans correlation coefficient r = 0.75, p = 0.05. This 
concluded that Gujarati version of ACE III is equivalent to original English ACE III 
and can be used to assess cognition in older adults. 
Thammanard Charernboon et al.82 (2014) This study was about to assess the 
accuracy of Thai version of the ACE III. 107 participants aged 60 or above were 
included in the study. The methods used in this study is forward and backward 
translation. This study shows that the Thai version of ACE (ACE – T) III is a valid 
and reliable cognitive assessment tool in the detection of MCI and early dementia in 
the Thai population.  
Hsieh S et al83 (2013) The aim of the study is to validate the newly developed 
version of Addenbrooke’s Cognitive Examination III against standardised 
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neuropsychological test and its predecessor. (ACE- R) in early dementia. In this 
study, 61 dementia patients and 25 controls were included in the study. ACE III 
cognitive domains correlated significantly with standardised neuropsychological test 
used in the assessment of language, visuospatial function, verbal memory and 
attention. The ACE III also compared very favourably with its predecessor, the 
ACE-R with similar levels of specificity and sensitivity. On the conclusion, this 
study provides objective validation of the ACE-III as a screening tool for cognitive 
deficit in FTD and AD.  
Latha Velayuthan et.al84. They aimed to review systematically brief 
cognitive tests for suspected dementia and report on their validation in different 
settings, to help clinician choose rapid and appropriate test. By using qualitative 
psychometric data the study was done. The results were obtained that Mini Mental 
State Examination and Hopkins Verbal Learning Test had good psychometric 
properties in primary care. Addenbrooke’s cognitive examination and Montreal 
cognitive assessment are effective to detect dementia with Parkinsons diseases and 
ACE-R is used for all dementia. Recently developed ACE-III show promise but 
need validation of test such as six CIT, abbreviated mental test is also needed for 
dementia screening in acute hospital settings. So the conclusion is practitioner 
should use tests as appropriate to the setting and individual patient.  
Roshaslina Rosli et al85 they aimed to rationalized the results of available 
study which were analysis the validity of cognitive tools for the detection of 
cognitive impairment and to identify the issues surrounding the available cognitive 
impairment screening tools in Asia. Here they used five electronic data base 
(CINAHL, MEDLINE, EMBASE, COCHRANE LIBRARY, SCIENCE DIRECT). 
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By the end of the study 38 articles, evaluating 28 tools in 7 Asian language were 
included. These tools were assessed in five studies. Highly variable cut off were 
reported for the MMSE and Montreal cognitive assessment, with 68%of studies 
reporting educational bias. From this they concluded that few cognition assessment 
tools have been validated in Asia, with no published validation studies for many 
Asian nation and languages. 
C.Bier et al86, (2003) they analysed that ACE, a simple instrument to 
differentiate fronto temporal dementia from Alzheimer’s diseases, in their dementia 
patient clinic population. The ACE was translate into French with adapation 
maintaining the number of word in the name and address learning and delayed recall 
test and with cultural adaptation. A diagnostic agreement was reached for 79 cases 
with 40 dementia, 25 AD, 9 Fronto Temporal Dementia. They estimated that the 
sensitivity for detecting dementia of an ACE score </=83/100 was 90%with a 
specificity of 64.1%they concluded that ACE is very accurate for the detection of 
dementia, but much less effective in discriminating the most common frontal variant 
of Frontal Temporal Dementia.  
S.M.C. Rasquin et al87 (2014), they conducted the study with the aim was to 
investigate the prognostic accuracy of different subtypes of mild cognitive 
impairment: amnestic MCI, multiple domain MCI, and single nonmemory domain 
MCI for the development of Alzheimer’s dementia(AD) and vascular 
dementia(VAD).As a result is multiple domain MCI had the higher sensitivity for 
both AD and VAD and amnestic MCI had the highest specificity. The positive 
predictive value was low for all subtypes whereas negative predictive value was 
high. On concluding, the subtypes multiple domain MCI has high sensitivity in 
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identifying people at risk for developing AD or VAD. The predictive accuracy of 
MCI subtypes was similar for both AD and VAD.   
Fang R et al.88 (2013) It was done to screen for Alzheimer’s disease(AD) or 
mild cognitive impairment (MCI) studies to validate the Chinese version of 
Addenbrooke’s cognitive examination of –revised (ACE-R) are rare. A total of 151 
subjects were included in the study and the neuropsychological assessments were 
employed. The validity of ACE –R to screen for mild AD and amnestic subtype of 
MCI was assessed by receiver operating characteristic curves. The result is the 
Chinese ACE-R is a reliable assessment tool for cognitive impairment. It    is more 
sensitive and accurate in screening for MCI rather than for AD compared to the 
MMSE. 
Yu J et al.89 (2012) the study was conducted to evaluate the effectiveness 
of the Beijing version of the montreal cognitive assessment (MoCA-BJ) as a 
screening tool to detect MCI among Chinese older adults. About 1001 Chinese older 
adults were included in the study. The MoCA-BJ demonstrated a sensitivity of 
90.4% and specificity of 31.3% within the cut off score of 26. When the cut off 
score was reduced to 22, the MoCA-BJ showed optimal sensitivity (68.7%) and 
specificity (63.9%). The MoCA-BJ is an acceptable tool for MCI screening in both 
urban and rural communities but due to the linguistic and cultural differences 
between the Chinese version and original English version and also the lower 
educational levels of Chinese older adults, the MoCA-BJ is not much better than 
MMSE in detecting MCI, atleast for this study sample.   
Iype T et al.90 (2006) the aim of the study was to examine the new cognitive 
screening test, the Rowland universal dementia assessment scale (RUDAS) and then 
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compare it with MMSE. About 116 subjects were included. Both screening tests 
were compared with regard to specificity and sensitivity. The correlation of both 
tests with years of formal education among the controls were assessed.  RUDAS had 
better specificity and similar sensitivity to MMSE, but did have an educational bias. 
As a conclusion, RUDAS is a useful brief screening test.  
Heo JH et al.91 (2012). This study was done to assess the diagnostic accuracy 
of the Korean version of the ACE (K-ACE) in about 115 subjects. The ACE was 
translated and modified to create the K-ACE. The area under the curve, reliability, 
verbal language/ orientation memory ratio, sensitivity and specificity were 
evaluated. The receiver operating characteristic (ROC) curve was used to determine 
the optimal cut-off score in dementia screening. In diagnosing AD and MCI, ROC 
curves showed that K-ACE is superior to Korean mini mental status examination. 
For identifying AD, the optimal cutoff of K-ACE was 68/69, which had a sensitivity 
of 90% and specificity of 84%.In the Korean elderly,the K-ACE is a short, reliable 
and valid neuropsychological test that is used to screen for dementia.  
Qiao J et al.92 (2015) In this study, cognitive impairments have been reported 
to be more common in non-demented patients with Parkinson’s disease and literacy 
plays an important role in intelligence. In this study, they included 69 consecutive 
Parkinson’s patients with over 6 years education level, MMSE score above 24 out of 
30 and they performed a battery of neuropsychological scales. By the result, there 
are extrinsic cognitive domain impairment in PD patients with normal global 
cognitive according to MMSE. Montreal cognitive assessment is a highly sensitive 
scale to screen cognitive impairments in PD. So they concluded that the cutoff score 
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of 28 on the MMSE screening for cognitive impairment in Chinese PD patients with 
high literacy levels may be more appropriate.  
Tunvirachaisakul C et al.93 (2018) To screen patient’s with Alzheimer’s 
dementia, the consortium to establish a registry for alzheimer’s disease developed a 
neuropsychological battery (CERAD- NP).Their aim was to delineate the CERAD-
NP features of MCI and their clinical utility to validate MCI diagnosis externally. 
About 60 patients with MCI and 63 normal controls were taken for the study. Using 
a combination of Wordlist call, Wordlist memory and verbal fluency test, MCI 
patients were discriminated from the controls. The most important CERAD-NP 
features differentiating MCI from normal controls indicate impairments in episodic 
and semantic memory and recall.While these features discriminate MCI patients 
from normal controls significantly, the tests are not predictive of MCI. 
McKhann G et al94 (1984) They aimed to 0develop clinical criteria for the 
diagnosis of Alzheimer’s disease include insidious onset and progressive 
impairment of memory and other cognitive functions. There are no motor, sensory 
or coordination deficits early in the disease. For this disease, diagnosis cannot be 
determined by the laboratory tests. These tests are important primarily in identifying 
the other possible causes for the dementia that must be excluded before the 
diagnosis of Alzheimer’s disease. By the conclusion, the criteria proposed are 
intended to serve as a guide for the diagnosis of Alzheimer’s disease. 
Persson K et al95 (2017) This study was done to whether visual assessment of 
medial temporal lobe atrophy (vaMTA) can predict 2 year conversion from mild 
cognitive impairment(MCI) to dementia and progression of MCI and Alzheimer’s 
disease  dementia as measured by clinical dementia rating scale. 94 patients with 
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MCI and 124 patients with AD were studied. vaMTA was associated with MCI 
conversion in an unadjusted model but not in an adjusted model (p= 0-075). In 
adjusted models, memory function, APOA ∑4 status and age were significant 
prediction of the disease progression, not vaMTA .The association between vaMTA 
and CDR –SB change was different in patient with MCI and AD dementia.  
Chandler MJ et al96 (2005).The study was to develop a total or composite 
score for the consortium to establish the registry for Alzhemier’s diseases(CERAD) 
neuropsycological battery. CERAD total scores were obtained by summing scores 
from the individual CERAD sub test in to a total composite. The results were 
obtained that the CERAD total score was highly accurate in differentiating NC and 
AD subjects in the CERAD registry. Age, gender and education effects were 
observed and demographic correction were derived through multiple regression 
analysis.Based on the results they concluded that the study provide support for the 
validity of the CERAD total score that can be used along with the normative data to 
provide an index of overall level of cognitive functioning from the CERAD 
neuropsychological battery.  
Karrasch M et al97 (2005) The aim of the study was to examine the 
consortium to establish a registry for Alzheimer’s disease (CERAD) test 
performances in patients suffering from amnestic mild cognitive impairment(MCI) 
and mild Alzheimer’s disease(AD).15 healthy elderly individuals, 15 amnestic MCI 
patients and 15 probable AD patients suffering from mild dementia were studied. 
The MCI group was differentiated from the controls only in the wordlist learning 
test. In the language test, the sensitivity to MCI and AD was quite low and the 
specificity was very high. In the savings scores the sensitivity to AD was high, but 
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the specificity rather low.Cutoff scores for the wordlist learning test and wordlist 
delayed recall that have been found to differentiate normal aging from dementia, are 
lacking in the finnish CERAD.The results indicate that the finnish CERAD test 
battery with its current cutoff scores has low sensitivity to MCI. The results indicate 
that the finnish CERAD test battery with its current cut off scores has low sensitivity 
to MCI and using it as a sole cognitive screening instrument for MCI and preclinical 
dementia might result in false negatives.  
Petersen RC et al.98 (1999) This study was to characterize clinically subjects 
with MCI cross sectionally and longitudinally. 76 consecutively evaluated subjects 
with MCI were compared with 234 healthy control and 106 patients with mild 
Alzheimer’s disease(AD), all from a community clinic setting. The results were 
obtained that the primary distinction between control subjects and subjects with 
MCI was in the areaof memory, while other cognitive functions were comparable. 
However, when the subjects with MCI were compared with the patients very mild 
AD, memory performance was similar, but patients with AD were more impaired in 
other other cognitive domains as well. Longitudinal performance showed that the 
subjects with MCI declined at a rate greater than that of the control. So they 
concluded that the patients who meet the criteria for MCI can be differentiated from 
healthy control subjects and those with mild AD.  
Broche-Perez Y et al.99 (2018) the aim of the study is to assess the diagnostic 
accuracy of the Cuban version of the revised Addenbrooke’s cognitive examination 
in identifying mild cognitive impairment in comparison with the mini-mental state 
examination. 129 elderly subjects were included in this study where Cuban ACE-R 
was administered. Cronbach’s coefficient α was used to evaluate the reliability of 
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psychometric scales. The Cuban ACE-R had reliable internal consistency. From the 
result, the Cuban ACE-R is a valid screening tool for detecting cognitive 
impairment. It is more sensitive and accurate in screening for MCI than MMSE.  
Larner AJ et al.100(2014) The ACE and its ACE-R are relatively new 
screening tools for cognitive impairment that may improve upon the well-known 
MMSE and other brief batteries. A meta analysis of suitable studies was conducted. 
From the result, they concluded that the ACE-R has somewhat superior diagnostic 
accuracy to the MMSE while the ACE appears to have inferior accuracy. The ACE-
R is recommended in both modest and high prevalence settings. Accuracy of newer 
versions of the ACE remain to be determined. 
Munoz-Nehra C et al. 101(2012) this study is to assess the cognitive 
capacities in dementia by Addenbrooke’s cognitive examination – revised as an 
alternative to MMSE. They also aimed to estimate the psychometric properties and 
diagnostic utility of the Addenbrooke’s cognitive examination- revised in a Chilean 
elderly population. Results were obtained that regarding convergent validity, the 
ACE-R-Ch showed significant correlation with another cognitive measure i.e 
MMSE. From the results they concluded that the ACE-R Ch showed acceptable 
psychometric properties, becoming a valid and reliable instrument to assess global 
cognitive efficiency or cognitive impairment. Its diagnostic utility to detect dementia 
patients also worked very well in a Chilean elderly sample. 
So M, Foxe D, Kumfor F et al 102 examined the relationship between the 
most recent version (ACE-III) and its predecessor (ACE-R), determined ACE-III 
cutoff scores for the detection of dementia, and explored its relationship with 
functional ability. Study 1: ACE-III and ACE-R scores differed by ≤1 point overall, 
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the magnitude varying according to dementia type. Study 2: a new lower bound 
cutoff ACE-III score of 84/100 to detect dementia was identified (compared with 82 
for the ACE-R). The upper bound cutoff score of 88/100 was retained. Study 
3: ACE-III scores were significantly related to functional ability on the 
Clinical Dementia Rating Scale across all dementia syndromes, except for semantic 
dementia. The results demonstrate that the ACE-III is an acceptable alternative to 
the ACE-R. In addition, ACE-III performance has broader clinical implications in 
that it relates to career reports of functional impairment in most common dementias. 
Peixoto B, et al.103, 2018 This study was to determine the psychometric 
properties of the Portuguese version of ACE-III, namely: reliability and 
discriminative validity (sensitivity and specificity) in the identification of mild 
cognitive impairment (MCI) and dementia the reliability of ACE-III was very good 
(α = 0.914). ACE-III significantly differentiated the 3 groups. The receiver operating 
characteristic (ROC) curves significantly favored ACE-III in comparison to another 
screening test - MoCA. ACE-III presented higher levels of sensitivity and 
specificity. Its total score correlated positively with the results on MoCA (ρ = 0.912; 
p < 0.001) and negatively with a depression scale (ρ = -0.505; p < 0.001). 
Portuguese version of ACE-III has very good reliability and high diagnostic capacity 
in the context of MCI and dementia. ACE-III also holds concurrent and divergent 
validity. 
Giebel CM, Challis D104 (2016) et al this exploratory study assessed  the 
sensitivity of Mini-Mental State Examination, Montreal Cognitive Assessment and 
the Addenbrooke's Cognitive Examination III each scale to everyday functioning 
and to examine the cutoffs between mild and moderate dementia on the ACE-III. 
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Thirty-three dyads completed the measures. Findings suggest the ACE-III more 
efficiently identifies everyday functional impairments. Further research is required 
to confirm these exploratory analyses of the cutoff between mild and 
moderate dementia on the ACE-III. Both functional impairment and stage 
of dementia are needed in the diagnostic process and in the clinical assessment of 
people with dementia.  
Robert  B Dudas et al105 (2005),concluded that  the total ACE score for the 
AD(Alzeimer’s disease) ,FTD( Fronto Temporal Dementia), and mixed groups were 
significantly lower  than the NC group likewise on total score the AD and FTD 
groups scored significantly lower than either of the pure affective disorder groups. 
Within the dementia group the AD group scored significant lower than the Fronto 
Temporal group. The profile of performance on the ACE of patients with dementia 
is different from that of the patients suffering from affective illness. Mild 
impairment in the total ACE score along either the low score on the memory domain 
tasks and letter fluency( in contrast to normal category fluency), as strongly 
indicative of an affective, as opposed to organic, pathology. A total score of <88 in 
suspected dementia patients with affective symptoms appear strongly predictive of 
an underlying organic disorder. 
Anabel Chade et al 106(2008) Study was aimed to investigate whether the 
Spanish version of the Addenbrooke’s Cognitive Examination (ACE) is capable of 
detecting cognitive difficulties in patients with Parkinson’s disease and 
discriminating their cognitive profile from patients with dementia.77 early dementia 
patients (53 with Alzheimer’s Disease and 24 with Frontotemporal Dementia), 22 
patients with Parkinson’s disease, and 53 healthy controls were evaluated with the 
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ACE. Parkinson’s disease patients significantly differed from both healthy controls 
and dementia patients on ACE total score. The study shows that the Spanish version 
of the ACE is capable of detecting patients with cognitive impairment in Parkinson’s 
disease and is able to differentiate them from patients with dementia based on their 
general cognitive status. 
Viviane Amaral Carvalho et al107 concluded from the study that the mean age 
of the studied sample of healthy elderly was 75.4years (ranging from 60-89 years). 
Small additional modifications were necessary after the evaluation of first 10 
subjects in order to improve comprehension of the test. The final Portuguese version 
of the ACE-R was produced and was found to be well understood by the remaining 
11 subjects taking an average of 15minutes to be administered. The Brazilian 
version of ACE-R proved to be a cognitive instrument for testing both in research 
and clinical setting. With this regard additional studies have been carried out in our 
unit in order to investigate the diagnostic properties of ACE-R in our mileu. 
Gaber TA et al108 this study aimed at evaluating the use of ACE-R and to 
establish its sensitivity compared to MMSE in a cohort of brain injury patients. The 
study revealed that among the 36 patients recruited 31males with a mean age of 37 
years and for a upper cut off value of 27/30 for MMSE and 80/100 for ACE-R, their 
respective sensitivities were 36% and 72 %respectively. For the lower cut-off value 
of 24/30 and 82/100 the test sensitivities were 11% and 56%, respectively. Analysis 
of the CE-R sub-tests indicated that memory and verbal fluency sub tests showed the 
most dramatic impairment. And hence the MMSE is insensitive as a screening test in 
a brain injury patients. The results show ACE-R to be sensitive and easily 
administered test.  
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Cheung G et al 109(2013) the aim of their study was to investigate the three 
common cognitive screening tools: the Montreal Cognitive Assessment(MoCA), the 
Rowland Universal Dementia Assessment scale(RUDAS), and the recently revised 
Addenbrooke’s Cognitive  assessment version III(ACE-R III). All the three tool 
discriminated well overall between the cases of mild dementia and controls . And 
they concluded that to inform the interpretation of these tests in clinical settings, it 
would be useful for future research to address more inclusive and potentially age-
stratified local norms. 
Craig G.J Newman et al110 (2018)The study was aimed to capture the rate 
and type errors in the clinical practice of Addenbroke cognitive examination III and 
then reduction in the error rate using a computerized alternative. In study 1,78% of 
clinically administered ACE-IIIs were either scored incorrectly or had arithmetical 
errors. In study 2, error rates seen in ACE-III were reduced by 85-93% using ACE 
mobile. 
Maria Sheila et al111 (2014) Had studied 70 idiopathic PD patients with a 
mean (SD) age of 64.1 (9.3) years and the mean disease duration of 7.7 (5.3) years 
and educational level of 5.9 years matched for education and age to controls. 27 
patients fulfilled MDS clinical criteria for PD dementia mean scores on the ACE-R 
were 54.7(12.8) points for patients with PD dementia, 76 (9.9) for PD patients 
without dementia and 79.7(1.8) points for healthy controls. The area under the 
receiver operating curve, taking the MDS diagnostic procedure as a reference, was 
0.93{95% Cl, 0.87-0.98: p< 0.001} for ACE-R. The optimal cutoff value for ACE-R 
</= 72 points {sensitivity 90%: specificity 85%: kappa concordance (k) 0.79}. ACE-
R appears to be a valid tool for dementia evaluation including patients with 
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heterogeneous education level, displaying good correlation with clinical criteria and 
diagnostic procedures of the MDS.  
Nadine Mirza et al112 proposed a study to develop the guidelines a 
compilation of all he adaptations, procedures undertaken by adapters of the ACE-III 
and its predecessors is needed. They deemed 32 papers suitable for analysis. 7 
translation steps were identified and they determined which items of the ACE-III are 
culturally dependent. The review lists all adaptation of the ACE, ACE-r and ACE-
III, rates the reporting of their adaptations procedures into steps that can be 
undertaken by adapters 
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MATERIALS AND METHODS 
 
Development of Instrument  
Malayalam version of ACE is translated in to Tamil and back translated 
necessary modification are made to suit the cultural based requirement. To develop 
normative value using Tamil version ACE in elderly subjects above 50yr of age 
attending Sree Mookambika Institute of Medical Sciences, Kulasekharam. 
Study Design:  Cross sectional study 
Study Settings: Patients coming to Sree Mookambika Institute of Medical Sciences. 
Duration of the study: 18 months  
Study groups: All patients above 50 years coming to Sree Mookambika medical 
college speaking Tamil will be taken into consideration in the study. 
Sample size of each group:  79 
Total sample size of the study: 79 
Scientific basis of sample size used in the study: 
𝑛 =
[Z1 √2𝑝(1 − 𝑝) +  Z2√𝑝1(1 − 𝑝1) + 𝑝2(1 − 𝑝2)]
2
[(p1 − p2)]2
 
n = sample size 
z1 = z value associated with alpha = 1.64 
p= average of p1+p2 
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p1 = probability of outcome in ACE-T i.e differentiate MCI = 0.9  
p2 = probability of outcome in ACE-T = 0.99 
z1 = z value associated with beta= 0.84 
n = 78.28 = 79 [22] 
Sampling technique used: Convenient sampling 
Inclusion criteria: 
 Patient more than 50 year male and female. 
Exclusion criteria: 
 Patients not willing 
 Critically ill patient. 
 Bed ridden and unconscious patient 
Methods.  
The ACE, which can be viewed as an Appendix on the Neurology Web site 
(www. neurology.org), consists of six components evaluating separate cognitive 
domains. A maximum score of 100 is weighted as follows: orientation (10), attention 
(8), memory (35), verbal fluency (14), language (28), and visuospatial ability (5). The 
orientation and attention components are as in the MMSE. The memory component 
evaluates episodic memory (recall of three items from the MMSE plus a “name and 
address learning and delayed recall” test) and semantic memory. The language 
component includes naming 12 line drawings, comprehension, repeating words and 
sentences, reading regular and irregular words, and writing.  
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Visuospatial testing consists of copying overlapping pentagons (from the 
MMSE) plus a wire cube, and drawing a clock face. Verbal fluency consists of letter 
fluency for words beginning with the letter P and category fluency for animals. Raw 
scores are used for all items except for verbal fluency: a scaled scoring system for 
the letter and category fluency was derived using a Gaussian distribution of the raw 
scores from normal controls included in this study (see the Appendix at 
www.neurology.org). Scores for each of the six domains can be calculated 
separately and their sum gives the composite score on the ACE. The MMSE score 
can also be calculated. The ACE can be administered in 15 to 20 minutes. 
M-ACE was administered to verify general cognition with special interest in M-
ACE registration and recall as specific measures of learning and retention. This battery 
has a global cognitive scale (mini - mental state examination, MMSE), and tests for 
memory (immediate and delayed recall of a seven-item address list), verbal fluency 
(initial letter P and categories of animals), confrontation naming (ten items), and 
constructional praxis (copying two line-drawings). It also assesses executive functions 
and constructional ability (clock-drawing), [13] remote memory, and language.  
Regsitration/learning is scored on a 24-point scale which has 3 points for 
registration of 3 words and 21 points for a 3-trial learning of an address. The recall score 
was drawn from a 10-point scoring which included a 5-min recall of the three items 
presented previously and 7-point recall of the address. Subjects were required to have 
depression score on the Hospital Anxiety Depression Scale (HADS) of less than 7, a 
Clinical Dementia Rating Scale (CDR) of ≤ 0.5, were still functioning independently in 
the community and should have a normal general cognition (i.e., MMSE > 24). The 
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standard measures of acquisition (learning) and retention (recall) considered were 
Malayalam versions of Wechsler Memory Scale-Revised (WMS-R) Logical Memory 
Test with Story A & B, Rey Auditory Verbal Learning Test (RAVLT) 
PROCEDURE IN BRIEF:     
 The study is to be carried out at Sree Mookambika Institute of Medical 
Sciences. Relavant clinical and demographic data will be obtained from the patient. 
Will document the age/sex/address/clinical information/ symptoms. 
Predisposing factors and any previous history of treatment /occupation/handedness/ 
Patient will be administered ACE CHART (Addenbrokes cognitive 
examination) and will be asked to do certain things. Patient will be made to recall 
things, identify pictures given in chart, check for verbal fluency, comprehension, 
repetition of words and assess visuospatial abilities. Based on this score patient will 
be given marks and the total score is calculated. 
STATISTICAL METHODS OF ANALYSIS: 
i. Significance level decided before starting of study: p=≤0.05 
ii. Statistical tests to be used for data analysis: Mean, Standard deviation 
and student t test 
iii. Software(s) used for statistical analysis: SPSS version 20.0 
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RESULTS 
 
Age: 
The distribution of age in the study population ranges from 51 to 89 years. 
The mean age of study participants was 63.14 years and a SD of 9.152 years. 
Table 3. Distribution according to age of participants 
 
 
 
 
 
 
 
 
 
 
 
Age characteristics 
(years) 
Values 
(N=100) 
Minimum 
Maximum 
Mean 
Standard deviation 
51 
89 
63.14 
9.152 
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Table 4. Distribution according to age group of participants 
Age group Frequency Percentage 
50-59 44 44 
60-69 34 34 
70-79 16 16 
80-89 6 6 
Total 100 100 
 
 
 
Fig. 2 Distribution of age in the study population 
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Table 5. Gender  
Gender Frequency Percentage 
Female 49 49 
Male 51 51 
Total 100 100 
 
 
 
Fig. 3 Distribution of gender in the study population 
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EDUCATION  
Table 6. Distribution according to ACE scoring of participants 
 
Education groups (years) Frequency Percentage 
1-4 20 20 
5-8 36 36 
9-12 30 30 
>12 14 14 
Total 100 100.0 
 
ACE scoring 
The distribution of ACE scoring in the study population ranges from 55 to 
65. The mean ACE scoring of study participants was 60.47 (95% CI is 60.024, 
60.915) and a SD of 2.271. 
Table 7. Distribution according to ACE scoring of participants 
 
 
ACE scoring 
Values 
(N=100) 
Minimum 
Maximum 
Mean 
Standard deviation 
55 
65 
60.47 
2.271 
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Comparison of ACE score in age groups 
In this study it is found that ACE score is significantly differ between 
different age groups (p<0.05) 
Table 8. Comparison of ACE score in age groups 
 
Age group Mean Std. Deviation Minimum Maximum 
50-59 61.4318 2.27624 57 65 
60-69 60.3824 1.74103 57 64 
70-79 58.8750 1.89297 56 62 
80-89 58.1667 2.04124 55 61 
Total 60.4700 2.27172 55 65 
 
 
 
Table 9. Comparison of ACE score in age groups 
 
ANOVA Table 
 
 
Sum of 
Squares 
df 
Mean 
Square 
F p value 
Between Groups 113.502 3 37.834 
9.139 0.000*** 
Within Groups 397.408 96 4.140 
Total 510.910 99    
 
 
 
 
Results 
 Page 54 
 
Comparison of ACE score in educational groups 
In this study it is found that the difference in ACE score between different 
educational groups are highly significant (p<0.05) 
Table 10.  Comparison of ACE score in educational groups 
Educational 
groups 
Mean Std. Deviation Minimum Maximum 
1-4 58.2500 1.65036 55 61 
5-8 59.5000 1.18322 57 62 
9-12 61.6667 1.53877 59 64 
>12 63.5714 1.55486 61 65 
Total 60.4700 2.27172 55 65 
 
Table 11. Comparison of ACE score in educational groups 
ANOVA Table 
 
 Sum of Squares df Mean Square F p value 
Between Groups 310.065 3 103.355 
49.402 0.000*** 
Within Groups 200.845 96 2.092 
Total 510.910 99    
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Table 12. Distribution of scores in different age group 
 
Minimum 
score 
Maximum 
score 
Overall 
(mean ± 
SD) 
Age group (in years) (mean±SD) 
50-59 60-69 70-79 80-89 
ACE score 55 65 
60.47  
± 2.27 
61.43  
± 2.27 
60.38  
± 1.74 
58.87 
± 1.89 
58.16
± 2.04 
Orientation 5 9 
7.08    
± 1.11 
7.09    
± 1.23 
7.12    
± 1.03 
7.19    
± 1.10 
6.50   
± 0.54 
Attention 1 3 
1.54    
± 0.52 
1.59    
± 0.49 
1.5      
± 0.56 
1.56    
± 0.51 
1.33   
± 0.51 
Concentration 1 4 
1.93    
± 0.82 
1.8      
± 0.85 
2.09    
± 0.75 
2.06    
± 0.92 
1.67  
±0.51 
Memory 1 2 
1.38     
± 0.48 
1.32    
± 0.47 
1.38    
± 0.49 
1.5     
± 0.51 
1.5     
± 0.54 
Antero grade 
memory 
7 15 
10.18   
± 1.69 
10.16   
±1.65 
10.41  
±1.87 
9.88   
± 1.62 
9.83  
±1.16 
Retro grade 
memory 
1 3 
1.74 
±0.747 
1.73    
± 0.75 
1.79    
± 0.77 
1.81    
± 0.75 
1.33  
±0.51 
Verbal fluency 5 9 
6.83    
± 1.05 
6.82     
± 1.16 
6.76    
± 0.95 
6.81   
± 1.10 
7.33   
±0.51 
Language 5 8 
6.4       
± 0.89 
6.41    
± 0.92 
6.38  
±0.92 
6.44    
± 0.81 
6.33  
±1.03 
Comprehension 1 2 
1.02    
± 0.14 
1± 0 
1.06    
± 0.23 
1± 0 1± 0 
Comprehension 
complex 
grammar 
1 1 1±0 1±0 1±0 1±0 1±0 
Repetition 
single words 
1 2 
1.42    
± 0.49 
1.45    
± 0.5 
1.35     
± 0.48 
1.5     
± 0.51 
1.33   
±0.51 
Repetition 
phrases 
0 1 
0.53     
± 0.50 
0.61     
± 0.49 
0.5      
± 0.5 
0.44    
± 0.51 
0.33  
±0.51 
Reading 
regular 
0 1 
0.44    
± 0.49 
0.48    
± 0.5 
0.38    
± 0.49 
0.44   
± 0.51 
0.5    
± 0.54 
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Reading 
irregular 
1 1 1±0 1±0 1±0 1±0 1±0 
Writing 1 1 1±0 1±0 1±0 1±0 1±0 
Visuospatial 
abilities 
1 1 1±0 1±0 1±0 1±0 1±0 
Clock 2 3 
2.46  
±0.5 
2.52  
±0.5 
2.44 
±0.5 
2.38 
±0.5 
2.33 
±0.51 
Perceptional 
abilities 
2 4 
2.82  
±0.73 
2.93 
±0.75 
2.76 
±0.69 
2.75 
±0.77 
2.5 
±0.54 
Recall 5 7 
5.93 
±0.74 
6.02 
±0.73 
5.85 
±0.74 
5.88 
±0.8 
5.83 
±0.75 
Recognition 3 5 
4.18 
±0.77 
4.09 
±0.83 
4.35 
±0.69 
4.06 
±0.77 
4.17 
±0.75 
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Table 13. Distribution of scores in different educational group 
 
Minimu
m score 
Maxim
um 
score 
Overall 
(mean 
± SD) 
Education groups (in years) (mean±SD) 
1-4 5-8 9-12 >12 
ACE score 55 65 
60.47 
±2.27 
58.25 
±1.65 
59.5 
±1.18 
61.66 
±1.53 
63.57 
±1.55 
Orientation 5 9 
7.08 
±1.11 
7.75 
±1.07 
6.94 
±0.98 
7±1.08 
6.64 
±1.27 
Attention 1 3 
1.54 
±0.52 
1.55 
±0.51 
1.61 
±0.49 
1.43 
±0.5 
1.64 
±0.63 
Concentrati
on 
1 4 
1.93 
±0.82 
1.6 
±0.68 
1.89 
±0.85 
2.07 
±0.74 
2.21 
±0.97 
Memory 1 2 
1.38 
±0.48 
1.45 
±0.51 
1.31 
±0.46 
1.43 
±0.5 
1.36 
±0.49 
Antero 
grade 
memory 
7 15 
10.18 
±1.69 
9.3 
±1.75 
10.47 
±1.63 
10.47 
±1.59 
10.07 
±1.73 
Retro grade 
memory 
1 3 
1.74 
±0.747 
1.6 
±0.75 
1.81 
±0.71 
1.8 
±0.76 
1.64 
±0.84 
Verbal 
fluency 
5 9 
6.83 
±1.05 
6.8±1.1 
6.86 
±1.01 
6.73 
±1.01 
7±1.24 
Language 5 8 
6.4 
±0.89 
6.55 
±0.94 
6.42 
±0.87 
6.47 
±0.9 
6±0.87 
Comprehens
ion 
1 2 
1.02 
±0.14 
1±0 
1.03 
±0.167 
1.03 
±0.18 
1±0 
Comprehens
ion complex 
grammar 
1 1 1±0 1±0 1±0 1±0 1±0 
Repetition 
single words 
1 2 
1.42 
±0.49 
1.4±0.5 1.47±0.5 1.4±0.49 
1.36 
±0.49 
Repetition 
phrases 
0 1 
0.53 
±0.50 
0.4±0.5 0.56±0.5 0.57±0.5 
0.57 
±0.51 
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Reading 
regular 
0 1 
0.44 
±0.49 
0.4±0.5 0.47±0.5 
0.37 
±0.49 
0.57 
±0.51 
Reading 
irregular 
1 1 1±0 1±0 1±0 1±0 1±0 
Writing 1 1 1±0 1±0 1±0 1±0 1±0 
Visuospatial 
abilities 
1 1 1±0 1±0 1±0 1±0 1±0 
Clock 2 3 
2.46 
±0.5 
2.3±0.47 2.56±0.5 2.43±0.5 2.5±0.51 
Perceptional 
abilities 
2 4 
2.82 
±0.73 
2.75 
±0.63 
2.83 
±0.77 
2.9±0.75 
2.71 
±0.72 
Recall 5 7 
5.93 
±0.74 
6.05 
±0.75 
5.83 
±0.73 
5.93 
±0.74 
6±0.78 
Recognition 3 5 
4.18 
±0.77 
4.4±0.75 
4.03 
±0.77 
4.13 
±0.81 
4.36 
±0.63 
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Table 14.   Distribution of scores among gender 
 
Minimum 
score 
Maximum 
score 
Overall 
(mean ± 
SD) 
Gender (mean ± SD) 
Male Female 
ACE score 55 65 60.47±2.27 60.62±2.39 60.3±2.15 
Orientation 5 9 7.08±1.11 7.02±1.19 7.14±1.04 
Attention 1 3 1.54±0.52 1.59±0.53 1.49±0.5 
Concentration 1 4 1.93±0.82 1.98±0.86 1.88±0.78 
Memory 1 2 1.38±0.48 1.51±0.5 1.24±0.43 
Antero grade 
memory 
7 15 10.18±1.69 10.08±1.71 10.29±1.68 
Retro grade 
memory 
1 3 1.74±0.747 1.67±0.71 1.82±0.78 
Verbal fluency 5 9 6.83±1.05 6.92±1.12 6.73±0.97 
Language 5 8 6.4±0.89 6.35±0.89 6.45±0.91 
Comprehension 1 2 1.02±0.14 1.04±0.19 1±0 
Comprehension 
complex 
grammar 
1 1 1±0 1±0 1±0 
Repetition 
single words 
1 2 1.42±0.49 1.37±0.48 1.47±0.5 
Repetition 
phrases 
0 1 0.53±0.50 0.59±0.49 0.47±0.5 
Reading 
regular 
0 1 0.44±0.49 0.47±0.5 0.41±0.49 
Reading 
irregular 
1 1 1±0 1±0 1±0 
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Writing 1 1 1±0 1±0 1±0 
Visuospatial 
abilities 
1 1 1±0 1±0 1±0 
Clock 2 3 2.46±0.5 2.45±0.50 2.47±0.5 
Perceptional 
abilities 
2 4 2.82±0.73 2.86±0.72 2.78±0.74 
Recall 5 7 5.93±0.74 5.92±0.74 5.94±0.74 
Recognition 3 5 4.18±0.77 4.25±0.77 4.1±0.77 
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Table 15.  Distribution of dementia based on orientation 
 
Dementia Frequency Percentage 
Dementia 65 65 
No dementia 35 35 
Total 100 100 
 
 
 
Fig.4 Distribution of dementia based on orientation in the study population 
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Table 16. Distribution of dementia based on attention 
 
Dementia Frequency Percentage 
Dementia 47 47 
No dementia 53 53 
Total 100 100 
 
 
 
 
Fig.5 Distribution of dementia based on attention in the study population 
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Table 17  Distribution of dementia based on concentration 
Dementia Frequency Percentage 
Dementia 33 33 
No dementia 67 67 
Total 100 100 
 
 
 
Fig.6 Distribution of dementia based on concentration in the study population 
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Table 18. Distribution of dementia based on memory 
Dementia Frequency Percentage 
Dementia 62 62 
No dementia 38 38 
Total 100 100 
 
 
 
Fig.7 Distribution of dementia based on memory in the study population 
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Table 19. Distribution of dementia based on anterograde memory 
Dementia Frequency Percentage 
Dementia 56 56 
No dementia 44 44 
Total 100 100 
 
 
 
Fig.8 Distribution of dementia based on anterograde memory in the study 
population 
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Table 20. Distribution of dementia based on retrograde memory 
Dementia Frequency Percentage 
Dementia 44 44 
No dementia 56 56 
Total 100 100 
 
 
 
Fig.9 Distribution of dementia based on retrograde memory in the study 
population 
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Table 21. Distribution of dementia based on verbal fluency 
Dementia Frequency Percentage 
Dementia 37 37 
No dementia 63 63 
Total 100 100 
 
 
 
Fig. 10 Distribution of dementia based on verbal fluency in the study population 
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Table 22. Distribution of dementia based on language 
Dementia Frequency Percentage 
Dementia 54 54 
No dementia 46 46 
Total 100 100 
 
 
 
Fig.11 Distribution of dementia based on language in the study population 
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Table 23.  Distribution of dementia based on comprehension 
Dementia Frequency Percentage 
Dementia 98 98 
No dementia 2 2 
Total 100 100 
 
 
 
 
Fig. 12 Distribution of dementia based on comprehension in the study 
population 
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Distribution of dementia based on comprehension complex grammar 
Based on comprehension complex grammar everyone have dementia (100%) 
in the study population. 
 
Table 24. Distribution of dementia based on repetition of single words 
Dementia Frequency Percentage 
Dementia 58 58 
No dementia 42 42 
Total 100 100 
 
 
 
Fig.13 Distribution of dementia based on repetition single words in the study 
population 
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Table 25. Distribution of dementia based on repetition of phrases 
Dementia Frequency Percentage 
Dementia 47 47 
No dementia 53 53 
Total 100 100 
 
 
 
 
 
Fig.14 Distribution of dementia based on repetition phrases in the study 
population 
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Table 26.  Distribution of dementia based on reading regular 
Dementia Frequency Percentage 
Dementia 56 56 
No dementia 44 44 
Total 100 100 
 
 
 
 
Fig.15 Distribution of dementia based on reading regular in the study 
population 
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Dementia based on reading irregular 
Based on reading irregular everyone have dementia (100%) in the study 
population. 
Dementia based on writing 
Based on writing everyone have dementia (100%) in the study population. 
Distribution of dementia based on visuospatial abilities 
Based on visuospatial abilities everyone have dementia (100%) in the study 
population. 
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Table 27. Distribution of dementia based on clock 
Dementia Frequency Percentage 
Dementia 54 54 
No dementia 46 46 
Total 100 100 
 
 
 
Fig.16 Distribution of dementia based on clock in the study population 
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Table 28 Distribution of dementia based on perceptional abilities 
Dementia Frequency Percentage 
Dementia 37 37 
No dementia 63 63 
Total 100 100 
 
 
 
 
Fig.17 Distribution of dementia based on perceptional abilities in the study 
population 
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Distribution of dementia based on recall 
Table 29 
Dementia Frequency Percentage 
Dementia 31 31 
No dementia 69 69 
Total 100 100 
 
 
 
 
Fig.18 Distribution of dementia based on recall in the study population 
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Table 30. Distribution of dementia based on recognition 
Dementia Frequency Percentage 
Dementia 60 60 
No dementia 40 40 
Total 100 100 
 
 
 
Fig.19 Distribution of dementia based on recognition in the study population 
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DISCUSSION 
 
To adapt and develop the normative value of ACE for Tamil speaking 
patients. 
 It is an instrument that defines the normative value of the patients who are 
not a k/c/o Dementia coming to our college. The ACE instrument developed by me, 
precisely diagnosed Dementia which the neurologists were not able to diagnose 
even after a detailed examination and with screening tools. Provided no other 
instruments for screening Dementia, mine was very precise in the diagnosis. 
This screening instrument tends to be cost effective among the Tamil 
speaking people and it can be easily used and instituted on patients even by the 
paramedical staffs if they are trained for a short period of time. It can be used as 
initial screening instrument at the peripheral centres where specialists are not 
available which may help in prompt referral for further management under the 
concerned speciality. Being cost effective, it reduces the expenditure for patients 
and it helps them by making it easy for them to go to the concerned specialists.  
All Medicos (MBBS, BAMS, MHW, FHW and Social workers) can 
institute this screening instrument on the patients to diagnose better and to refer 
them for faster treatment.  
In a Country like India where resources are very less, most of the people 
belong to the middle class and cannot afford costly investigations. 
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My study shows:    
1. Normative value in all people who were included in the study. 
2. It is according to the contribution of age, gender and education. 
3. As age increases ACE score comes down. 
4. Higher the education higher the ACE score. 
These modification of the ACE, translated and adapted in Tamil does not 
differ a lot from the Malayalam version of ACE and the original ACE. 
Cognitive evaluation constitutes as an important tool for the assessment of 
cerebral functioning, being mandatory for the differential diagnosis between the 
normal ageing, mild cognitive impairment dementia and its subtypes. ACE includes 
the assessment of different cognitive domains such as orientation, memory, 
attention, verbal fluency, language and visuo-spatial ability. 
My translated version of the ACE  which was used to adapt and develop 
normative value for Tamil speaking patients, was found to be a promising tool for 
clinical use and validation in our population. 
TRANSLATION INTO TAMIL: 
Translation of Malayalam ACE into Tamil ACE was done with the help of 
linguistic person. 
I preferred translating from Malayalam ACE for the following reasons:  
 Kulasekharam is a village in the border of state Tamil Nadu between 
Kanyakumari and Trivandrum. 
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 Mixture of culture.  
 Same food culture. 
 Most of the people understand Malayalam and Tamil. 
 Things used on a daily basis by the Malayalis are similar to the ones used by 
the Tamilians. 
 The literacy rates between the two places are similar since Kulasekaram was 
previously a part of Kerala. 
 Male and female ratio is also similar to Trivandrum and similar festivals are 
celebrated in both these areas 
 Policy guidelines and administrations are similar in both Trivandrum and 
Kulasekaram. 
 Migration of people between Trivandrum and to areas along the Tamil Nadu 
borders are very frequent. 
 Agricultural techniques followed and the pattern of food grown in this part 
is similar to Kerala. 
 Geographic wise Kulasekaram (Kanyakumari, Tamil Nadu) was a part of 
Kerala. In 1957, it was divided and included in the state of Tamil Nadu and 
both the areas are blessed with a rich nature diversity. 
 Religion, caste and creed distribution in both these areas tend to be the same. 
 Being a tourist place culture practiced in various parts of India can be seen here. 
The above mentioned points highlighting the similarities are the reason for 
me preferring translation from the Malayalam ACE version.  
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Comparing with the M-ACE study: 
Comparing our study to the study conducted by P. S. Mathuranath el al., on 
Adaptation of the ACE for a Malayalam speaking population in southern India, the 
mean age group of our population was found to be 63.14years and a SD of 9.152 
years. In the study conducted by P S Mathuranath et al., Indian population was 
compared with UK population. UK population was screened using the ACE 
original English version. Indian population was screened using the Malayalam ACE 
(mACE). To establish the equivalence of tests between the m-ACE and the ACE, 
the Indian cohort was educationally stratiﬁed into two groups- ‘India >9’ (n-50 with 
education >9) and ‘India <8’ (n-50 with education <8) so as to allow for an 
education fair cross-national comparison as UK minimum education years was nine 
years. Similarly our group was stratified into two educational group- one with <9 
years of education and other with >9years of education. The total ACE score of our 
population was relatively lower than both the Indian and UK population in both 
educational group. UK population had a mean ACE score of 93.9 whereas mean 
ACE score of the 'India >9' was 83.6. But chosen population had a lower ACE 
score of 62.61905. Similarly, 'India < 8' has a mean ACE score of 59.0 comparable 
to our population with less than 8 years of education with ACE score of 58.875. 
These differences in Education plays a major role in determining ACE score in both 
Malayalam speaking population and our Tamil speaking population. Individual 
components in both the study groups were comparable. Orientation in UK 
population, 'India >9' group and 'India <8' group was 9.8, 7.8 and 6.4 respectively. 
So was the results of our population, education more than 9 years and education 
less than 8 years had scores of 7.345 and 6.82 respectively. Similarly, Verbal 
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Fluency was much affected in our population compared to the Malayalam speaking 
population. Mean score of verbal fluency in India>9 of Malayalam speaking 
population and our population with more than 9 years of education is 9.1 and 6.83 
respectively. Whereas the difference in the score was not much high when 
compared the lower education year population. (7.1 in Malayalam speaking Vs 6.86 
in Tamil speaking). In Language, mean score in UK population and Malayalam 
speaking population is relatively higher than that of Tamil speaking population with 
education more than 9 years. (15.8 and 15.9 out of 16 Vs 6.83 out of 10).  
COMPARISON WITH OTHER STUDIES: 
On comparing the separate sub score values with the study of Carvalhov et 
al., age influenced the verbal fluency sub-scores. With lower age group there was a 
decrease in ACE score (50-59 years, 6.82 Vs 80-89 years, 7.33). Similarly, we 
obtained a lower sub-scores for ability to draw a clock with increasing age group. 
(50-59 years, 2.52 Vs 80-89 years, 2.33). 
In contrast to our study, which includes relatively higher number of females, 
the study conducted by Alexopoulos et al., revealed a significantly fewer female 
participants than healthy controls. 
  According to the study on the Slovak population, the score range in the 
patient group it varied from 11- 80 with the mean of 53.87. Age and education were 
shown to significantly influence the test performance while there was no significant 
difference between sexes in the obtained score. A significantly different 
performance was observed between all three age groups where the obtained score 
tended to decrease with age. A similar effect was also observed in the three 
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education levels where participants with low education performed significantly 
lower than participants with high and advanced education, and highly educated 
people achieved a lower score than advanced educated individuals. Same result was 
applicable in our study. 
DRAWBACKS OF THE STUDY:  
Major drawbacks of the study was that it was hospital based. The evaluation 
was not done on completely normal people as they visited the hospital mainly due 
to other medical problems. The normal population could not be included because it 
does not show the uniformity of population of Tamil Nadu. The ACE was mainly 
applied on the patients who had come for other ailments to diagnose Dementia. 
The size of the sample in our study was very confined and small as 
compared to the other studies and also the other studies were community based ours 
being hospital based.   
 It is hospital based study. 
 Not community based. 
 Small number of people involved in this study. 
 Patients not included from:  
1.  SICU   
2. IMCU, 
3. CT-ICU, 
4. ICCU, 
5. Trauma patients,  
6. Head injury cases 
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7. Patients under drug influence  
8. Patients under alcohol. 
 The Tamil ACE is not yet approved and formally validated. It has to be 
subjected to exclusive clinimetric evaluation across the various sample of TN 
population highlighting the need for future research in this regard. 
HIGLIGHTS OF THE STUDY: 
 With increase of the age ACE score was low. 
 Higher the education higher the ACE score in dementia patients. 
 Age distribution among our study: 
  Max- 89, Min-51, Mean- 63.14 
 Gender distribution among our study 
  Male -51, Female-49 
 ACE score in our study 
  Max- 65, Min-55, Mean-60.47 
 Our study showed that ACE score significantly differ between different age 
group (p<0.05) of our study. 
 Our study showed that 65% patients were diagnosed with Dementia using 
T-ACE( Tamil version of ACE) 
 Attention being one the parameters for the diagnosis of Dementia, our study 
showed that 47% people had attention deficit.   
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 Memory being the other parameters for the diagnosis of Dementia, our 
study showed that 62% people had memory impairment.  
 Verbal fluency being the other parameters for the diagnosis of Dementia, 
our study showed that 63% people had verbal fluency problem (one of the 
major highlights of the study).   
 Visuospatial abilities being the other parameter for the diagnosis of 
Dementia, our study showed that 54% people had visuospatial problems.   
 Recognition being the other parameters for the diagnosis of Dementia, our 
study showed that 60% people had recognition difficulties. 
 Using ANOVA test results were found to be similar between my study and 
other studies.  
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CONCLUSION 
 
 Tamil version of ACE is comparable with the original ACE as far as 
performance in normal elders are concerned. 
 ACE score correlates well with education of normal elderly. 
 T-ACE correlates well with age of normal elderly. 
 Major drawbacks of the study was small sample size and hospital based 
sampling. Here the study was replicated on larger community based population 
before it could be applied to the population. 
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SUMMARY 
 
 T-ACE appears to be good tool to diagnose Dementia in Tamil speaking 
patients. 
 T-ACE score correlates well with education and age in normal elderly. 
 It is cost effective, user friendly and can be instituted by paramedical staff 
for further referral to the concerned specialist. 
 It can be used in the peripheral centres, which lack specialists, hence 
reducing the expenditure of visiting many hospitals for patients. 
 It is a hospital based study and was applied only to a small scale population 
of Tamil Nadu which remains as the main drawback of the study. 
 To be applied to larger population and community to diagnose Dementia. 
 This remains as an area for further research and studies, which might enable 
the clinicians across the state to diagnose Dementia better. 
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 APPENDIX – IV 
MASTER CHART 
S.NO IP.NO GENDER AGE 
ACE 
SCORING 
EDUCATION 
ORIENTATION 
(0-10) 
ATTENTION  
(0-3) 
CONCENTRATION 
(0-5) 
MEMORY 
(0-3) 
ANTEROGRADE 
MEMORY (0-21) 
RETROGRADE 
MEMORY(0-4) 
VERBAL 
FLUENCY 
(0-14) 
1 15026726 M 52 57 5 6 1 2 1 10 2 7 
2 15041170 F 56 60 7 7 2 3 2 11 3 6 
3 15059413 M 58 56 8 8 2 4 2 12 2 5 
4 15062271 F 68 57 6 7 2 2 1 15 3 6 
5 15076319 F 70 65 10 9 1 3 2 11 3 6 
6 15080997 M 62 65 12 8 1 1 2 12 3 6 
7 15095964 F 57 63 GRAUDUATE 6 1 1 2 12 3 5 
8 15098128 M 65 62 5 5 1 1 2 11 3 5 
9 15107152 M 57 61 
TEACHER 
BSE 
5 2 2 2 14 3 5 
10 15107234 M 66 56 11 6 2 2 1 13 3 5 
11 15110852 M 57 57 4 7 1 3 2 11 2 5 
12 15128354 F 63 58 7 8 2 1 1 12 3 6 
13 15135105 F 59 59 9 9 1 2 2 11 3 5 
14 15136290 F 71 57 11 6 1 3 1 12 2 6 
15 15142543 F 57 58 12 5 2 3 1 12 3 5 
16 15145324 M 55 56 4 8 1 1 2 11 3 6 
17 15146492 M 52 58 2 9 2 1 2 14 3 5 
18 15160497 F 62 59 5 7 1 2 2 13 3 6 
19 15161172 F 72 60 10 8 2 3 2 13 3 5 
20 15167146 F 54 61 LLB 9 2 3 1 11 3 6 
21 15170435 M 63 55 7 6 2 2 1 11 2 5 
22 15177151 F 55 56 6 8 1 1 1 11 2 6 
23 15183055 F 67 64 1 7 1 2 1 11 3 5 
24 15192122 F 77 61 ENGINEER 6 2 2 1 11 2 8 
25 15197348 M 58 56 9 8 1 2 2 13 2 8 
26 15198491 F 54 57 7 9 2 2 1 11 2 7 
27 15199251 F 66 65 8 7 2 3 1 14 2 8 
28 15209243 M 61 61 9 6 1 3 2 11 2 7 
29 15211530 M 56 61 4 8 2 1 1 11 1 8 
 30 15214979 F 51 56 7 7 2 1 1 11 2 7 
31 15217726 F 54 61 11 6 1 2 1 10 1 8 
32 15219301 M 60 57 5 8 1 3 2 12 1 8 
33 15234692 M 76 58 MBA 7 2 4 2 10 2 6 
34 15247330 M 65 59 BARBER 9 7 1 2 1 9 1 7 
35 15018287 M 54 60 1 8 2 2 1 9 2 8 
36 16039263 F 55 60 3 9 2 3 1 9 1 6 
37 16042484 M 71 60 5 9 2 1 1 9 2 8 
38 16047212 M 52 62 2 9 2 1 2 9 1 8 
39 16061760 M 66 63 4 8 2 2 2 9 2 7 
40 16075472 F 67 64 6 8 2 3 1 11 1 7 
41 16077209 F 68 64 9 7 1 4 1 12 1 6 
42 16085323 M 70 65 8 7 1 3 2 9 1 6 
43 16086810 F 53 63 7 8 2 2 1 12 2 8 
44 16104478 M 62 55 
BSE 
NURSING 
9 3 3 1 11 2 6 
45 16113048 M 54 55 6 7 2 4 2 11 1 6 
46 16119243 F 51 57 7 6 1 1 1 10 2 5 
47 16134828 M 54 56 9 6 2 2 2 10 2 6 
48 16135166 M 57 57 11 6 2 2 2 9 2 7 
49 16138503 F 66 58 12 6 1 2 1 10 2 7 
50 16142258 F 63 58 CKERK 10 7 1 2 1 10 2 8 
51 16148107 F 74 63 2 8 2 2 2 10 2 7 
52 16148144 M 66 56 3 9 1 2 2 9 2 8 
53 16167273 F 69 57 4 7 2 2 2 9 1 7 
54 16205154 F 56 58 5 6 1 2 1 10 2 8 
55 16214585 M 59 60 7 5 2 1 2 11 2 7 
56 16215769 F 63 59 8 7 1 2 2 10 2 8 
57 16229043 M 67 64 9 8 2 2 2 13 2 7 
58 16241460 F 74 65 10 7 1 2 2 11 2 8 
59 17005713 M 69 64 11 8 2 2 2 11 2 7 
60 17016159 F 58 60 2 7 1 2 1 10 2 8 
61 17016494 M 76 60 3 6 2 1 1 9 1 8 
62 17021985 F 88 60 BSE 7 1 1 1 9 1 7 
63 17029551 M 58 64 DENTAL 8 2 2 1 8 1 8 
64 17033196 F 77 58 BTECH 7 1 1 1 10 1 7 
65 17057430 M 54 59 MBA 6 1 1 1 11 1 8 
66 17073643 F 51 57 5 6 2 1 1 10 1 7 
67 17087014 M 53 56 12 7 2 1 1 11 1 8 
 68 17093691 F 60 57 5 8 1 1 1 10 2 7 
69 17099302 M 80 56 8 7 2 1 2 10 1 7 
70 17111652 M 81 56 5 6 1 2 1 11 2 8 
71 17123886 M 86 57 9 7 1 2 2 11 1 7 
72 17126402 M 82 58 12 6 2 2 1 10 2 8 
73 17128476 F 55 57 6 7 2 2 1 10 2 7 
73 17129084 M 53 56 8 7 2 2 1 8 1 8 
74 17131423 F 57 56 7 6 1 2 1 9 1 7 
75 17135011 F 56 64 9 6 1 2 1 8 1 8 
76 17135417 M 67 64 7 6 2 2 1 8 1 7 
77 17151103 M 60 65 6 7 2 2 1 9 1 8 
78 17151131 M 65 56 11 7 1 3 1 9 1 8 
79 17168619 M 58 57 TEACHER 6 2 3 1 9 1 9 
80 17176885 M 53 58 LLB 6 1 2 1 8 1 8 
81 17185485 M 61 56 BA 5 2 3 2 9 1 7 
82 17192709 M 69 65 mbbs 6 1 3 2 8 1 8 
83 17200260 F 89 63 4 6 1 2 2 8 1 7 
84 17201146 F 57 64 7 7 2 1 1 9 1 8 
85 17205812 F 65 65 8 8 2 1 1 9 1 7 
86 17214874 F 58 57 4 8 2 1 1 7 1 8 
87 17216041 F 51 59 9 8 2 1 1 9 1 7 
88 17224936 M 54 59 1 9 1 1 1 7 1 6 
89 17225253 M 73 60 2 7 1 1 1 7 1 6 
90 17229591 F 73 60 12 6 2 2 2 9 1 6 
91 17230836 M 77 57 5 6 2 2 2 11 3 9 
92 17239152 M 64 58 7 7 1 2 1 8 1 7 
93 17241610 F 54 64 9 8 2 1 1 9 1 7 
94 17243203 F 76 61 3 9 1 1 1 7 1 7 
95 17253082 M 64 62 9 9 1 1 1 9 2 6 
96 17254832 M 69 61 11 7 2 2 1 9 1 7 
97 17257522 F 52 61 4 6 1 1 1 9 1 6 
98 17257545 F 53 63 7 6 1 1 1 7 1 7 
99 17265300 F 77 57 8 7 2 2 1 9 2 6 
100 18011942 M 67 64 9 6 1 1 1 7 1 6 
 
 
 
 LANGUAGE 
(0-10) 
COMPREHENSION   
(0-2) 
COMPREHENSION 
COMPLEX GRAMMAR 
(0-2) 
REPETITION 
SINGLE WORDS 
(0-3) 
REPETITION 
PHRASES (0-1) 
READING 
REGULAR 
(0-1) 
READING 
IRREGULAR 
(0-1) 
WRITING 
(0-1) 
VISUOSPATIAL 
ABILITIES (0-1) 
CLOCK 
(0-3) 
PERCEPTIONAL 
ABILITIES  (0-4) 
RECALL  
(0-7) 
RECOGNITION 
(0-5) 
6 1 1 2 1 1 1 1 1 2 2 5 3 
5 1 1 1 1 0 1 1 1 3 3 6 4 
5 1 1 2 1 0 1 1 1 2 4 7 5 
6 1 1 2 0 0 1 1 1 2 2 6 4 
6 1 1 1 1 0 1 1 1 2 3 5 5 
7 2 1 2 1 0 1 1 1 3 4 7 4 
5 1 1 2 1 1 1 1 1 3 2 7 5 
6 2 1 1 1 1 1 1 1 3 3 7 3 
6 1 1 1 1 1 1 1 1 2 3 6 4 
7 1 1 1 1 0 1 1 1 2 3 5 3 
5 1 1 1 0 1 1 1 1 2 3 5 4 
6 1 1 1 0 0 1 1 1 3 4 6 5 
7 1 1 2 1 1 1 1 1 2 2 7 4 
6 1 1 1 0 0 1 1 1 2 4 6 3 
7 1 1 2 0 0 1 1 1 3 3 7 4 
8 1 1 2 1 1 1 1 1 3 4 6 5 
7 1 1 1 1 0 1 1 1 2 3 7 3 
6 1 1 1 0 1 1 1 1 3 2 6 4 
7 1 1 2 0 1 1 1 1 2 4 6 5 
7 1 1 1 0 0 1 1 1 3 3 7 4 
7 1 1 1 1 1 1 1 1 2 2 7 5 
6 1 1 1 0 1 1 1 1 3 3 6 3 
7 1 1 1 0 0 1 1 1 2 2 7 4 
6 1 1 1 1 0 1 1 1 3 3 7 4 
6 1 1 1 1 1 1 1 1 3 4 6 5 
6 1 1 1 1 1 1 1 1 2 4 5 3 
6 1 1 2 1 0 1 1 1 2 3 7 4 
6 1 1 1 0 1 1 1 1 3 3 5 5 
7 1 1 2 0 0 1 1 1 3 3 6 5 
6 1 1 2 0 0 1 1 1 2 2 5 3 
7 1 1 2 1 1 1 1 1 3 2 6 4 
6 1 1 1 1 1 1 1 1 2 3 6 5 
 7 1 1 2 0 0 1 1 1 2 2 7 4 
6 1 1 1 0 1 1 1 1 3 3 5 5 
7 1 1 1 1 0 1 1 1 3 2 6 5 
6 1 1 1 1 0 1 1 1 2 3 6 3 
7 1 1 2 1 1 1 1 1 3 4 5 4 
7 1 1 2 1 0 1 1 1 3 4 7 3 
6 1 1 1 1 1 1 1 1 2 3 6 4 
7 1 1 2 1 0 1 1 1 3 4 5 4 
8 1 1 1 1 0 1 1 1 2 3 6 5 
7 1 1 1 1 0 1 1 1 3 2 5 3 
8 1 1 2 1 0 1 1 1 3 3 7 5 
8 1 1 2 1 1 1 1 1 2 3 5 4 
7 1 1 1 1 0 1 1 1 2 3 6 4 
8 1 1 2 1 1 1 1 1 2 4 6 4 
8 1 1 1 1 0 1 1 1 2 2 6 4 
7 1 1 1 1 1 1 1 1 3 3 5 3 
8 1 1 2 0 0 1 1 1 2 2 5 4 
7 1 1 1 0 0 1 1 1 3 2 6 3 
8 1 1 2 0 1 1 1 1 2 3 5 4 
7 1 1 1 0 1 1 1 1 3 2 6 5 
8 1 1 2 0 0 1 1 1 2 2 5 5 
7 1 1 1 0 1 1 1 1 2 3 5 4 
7 1 1 1 1 0 1 1 1 2 2 6 3 
7 1 1 2 1 0 1 1 1 3 2 5 4 
7 1 1 1 0 0 1 1 1 2 3 6 3 
7 1 1 2 1 0 1 1 1 3 2 6 4 
7 1 1 1 1 0 1 1 1 2 2 6 5 
6 1 1 1 1 0 1 1 1 2 3 6 5 
7 1 1 1 0 1 1 1 1 2 2 5 5 
6 1 1 1 0 1 1 1 1 2 2 5 3 
6 1 1 1 0 0 1 1 1 3 3 6 4 
6 1 1 1 1 1 1 1 1 2 2 6 5 
6 1 1 1 1 0 1 1 1 3 2 6 5 
8 1 1 1 1 1 1 1 1 3 3 5 3 
 7 1 1 1 0 0 1 1 1 2 2 7 5 
6 1 1 1 0 0 1 1 1 3 2 7 5 
8 1 1 1 0 0 1 1 1 2 3 6 4 
6 1 1 1 0 1 1 1 1 3 2 6 4 
7 1 1 2 1 0 1 1 1 3 3 5 5 
6 1 1 2 0 1 1 1 1 2 2 7 4 
7 1 1 2 0 1 1 1 1 3 3 5 5 
6 1 1 1 0 1 1 1 1 2 4 5 5 
7 1 1 2 1 1 1 1 1 2 4 6 3 
6 1 1 1 0 1 1 1 1 3 4 7 4 
7 1 1 2 1 0 1 1 1 2 3 6 5 
6 1 1 1 1 1 1 1 1 3 4 6 4 
6 1 1 2 1 0 1 1 1 2 3 6 4 
5 1 1 1 1 0 1 1 1 3 4 5 5 
6 1 1 2 0 1 1 1 1 2 4 6 4 
5 1 1 1 0 1 1 1 1 3 2 5 5 
5 1 1 2 1 1 1 1 1 2 3 6 5 
5 1 1 1 1 0 1 1 1 2 3 6 5 
6 1 1 2 0 0 1 1 1 3 2 6 5 
5 1 1 1 0 0 1 1 1 3 2 5 4 
6 1 1 2 0 1 1 1 1 2 3 6 5 
5 1 1 1 1 0 1 1 1 2 4 5 3 
6 1 1 2 0 1 1 1 1 3 2 7 5 
5 1 1 2 0 0 1 1 1 2 3 5 4 
6 1 1 1 1 1 1 1 1 2 3 6 3 
5 1 1 2 0 0 1 1 1 3 2 7 3 
6 1 1 1 0 1 1 1 1 2 3 5 4 
5 1 1 2 1 1 1 1 1 3 2 6 3 
6 1 1 1 0 0 1 1 1 2 3 7 4 
5 1 1 2 1 0 1 1 1 2 4 5 5 
5 1 1 1 0 0 1 1 1 3 3 6 5 
7 1 1 1 0 0 1 1 1 2 2 7 5 
5 1 1 2 0 0 1 1 1 3 3 5 5 
7 1 1 2 0 1 1 1 1 3 2 6 5 
5 1 1 1 0 0 1 1 1 2 3 7 5 
 
